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Abstract
Advances in biophysical characterisation through micron scale flow engi-
neering
KADI LIIS SAAR
Department of Chemistry, University of Cambridge
Proteins are the chief actor molecules of cells central to the majority of biochemical
and biophysical processes that sustain life. Interactions between proteins and other
biomolecules are crucial to a faultless execution of biological function, yet it has re-
mained challenging to analyse these biomolecular interactions with current protein
science tools - they commonly rely on non-physiological conditions for performing
analysis, thereby compromising the ability to analyse biological interactions.
This thesis describes the development and applications of platforms that facilitate
rapid analysis of heterogeneous systems of proteins and protein interactions directly
in solution, under fully native conditions. I achieved this objective by fabricating
micron scale structures, where, in contrast to macroscale systems, chaotic mixing
of fluids and the molecules therein was suppressed. In this manner, I was able to
dispense with the support structures that prevent mixing in conventional protein analy-
sis platforms and decrease analysis times by orders of magnitude, from hours to seconds.
The first part of the thesis was centred around the use of micron scale strategies
for probing proteins, protein interactions and protein self-assembly in vitro. First, I
demonstrated a platform for performing automated high-throughput measurements
on protein self-assembly in a label-free environment. I proceeded by addressing two
challenges at the core of creating micron scale separation platforms - the integration
of strong and stable electric fields with micron scale channels and the enhancing of
the resolution limit of such separation systems. Finally, I devised and demonstrated
devices for combined biomolecular separation and analysis, which allowed me to size
mixtures of proteins at an unprecedented resolution and gain multidimensional data
x
on biomolecular systems.
The second part focussed on probing protein behaviour inside cells. I first described a
strategy for detecting intracellular proteins in individual cells in a high throughput
manner, offering a substantially advanced multiplexing capability in comparison to
existing approaches for analysing intracellular proteins. I then focussed on a specific
application of cellular biophysics and measured electrical outputs of cells. This work
led to record high power outputs for systems that use biological matter for converting
sunlight into electricity. To my knowledge, this was also the first demonstration of a
biological solar cell equipped with energy storing capacity, the lack of which had been
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1.1 Proteins and protein interactions
Proteins are the chief effector molecules of cells, forming the basis of the molecular machinery
that sustains life. Proteins and their complexes play a central role in a diverse range of
cellular processes, including replication of genetic information, catalysis of metabolic reactions,
transportation of cargo into and out of cells, transmission of the signals involved in body’s
immune response against foreign invaders and regulation of the folding and unfolding of other
proteins, thereby enabling their function [1–3]. Thus, a faultless behaviour of proteins is of
paramount importance to well balanced cellular function and, ultimately, to our well being,
whereas its disrupted behaviour, on the contrary, is associated with the onset and progression
of an increasingly larger number of disease states [4–7].
While the analysis of individual proteins can shed light onto their key properties and thereby
aid us in understanding protein function and activity, in the dynamic and crowded environ-
ment of cells [8–10], proteins are in constant contact with each other and frequently carry
out their functions as part of larger complexes or assemblies [11–16]. Indeed, any one of
the aforementioned biochemical processes takes place through an interplay between proteins
of differing functions or involve their interactions with other biomolecules, such as lipids,
oligonucleotides or small molecule ligands. It has been estimated that over 80% of proteins
do not perform their function on their own but through interacting with other molecules [17]
with the interactions being frequently transient and non-covalent in their nature [18–20]. This
tendency firmly highlights the requirement for analysing proteins with tools that function
directly in solution and under native conditions where such biomolecular interactions can be
2 Introduction
preserved. However, due to the tendency of fluids to uncontrollably mix, in-solution analysis
of heterogeneous mixtures of proteins has remained a challenging goal to reach. As such,
the analysis of heterogeneous protein mixtures is usually achieved through operation in the
gaseous phase or on a solid support medium as I will discuss in more detail in Section 1.2. In
both of these scenarios, care has to be taken to ensure that all interaction between proteins
and their binding partners remain intact when samples are transferred away from their native
solution phase.
In this thesis, I focus on the development and application of methods that permit in vitro
systems of proteins, protein complexes and protein interactions to be probed directly in
solution. I will achieve this objective predominantly through the use of micron scale fabrication
and flow engineering approaches that allow exerting tight control over fluid behaviour and,
thereby, quantitative characterisation of protein properties and behaviour. Moreover, I will
also explore the possibilities of extending these analysis strategies to describing the behaviour
of intact cells and to detecting and probing proteins inside a cellular environment.
1.2 Protein characterisation and analysis tools
The past decades have seen remarkable developments in techniques that permit highly
accurate structural characterisation of biomolecules, often down to atomic resolution. X-
ray crystallography and, as of more recently, cryogenic electron microscopy (cryo-EM) in
particular have extensively advanced our understanding of the structures of key proteomic
species [21–26]. These methods have been historically used for resolving the structures
of individual proteins, yet recent advancements in the sample preparation process have
allowed their application to resolving the structures of macromolecular complexes, such as
ribosomes [27, 28].
While the focus of aforementioned techniques has been to obtain highly resolved structural
information on proteins in their fixed states, different types of analysis approaches have
been developed for probing the dynamic behaviour of proteins. The latter objective can be
achieved when the analysis is performed in a rapid manner and in the native environment of
biomolecules, which in the case of in vitro studies is usually mimicked through the use of
physiological buffers. Such conditions ensure that the interactions between protein molecules
or between proteins and their ligands are fully preserved throughout the analysis while the
rapid analysis speeds guarantee that it is possible to probe the dynamic behaviour of such
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protein based systems.
In-solution characterisation of proteins can be achieved through a number of biophysical
methods. For instance, dynamic light scattering (DLS) [29], and fluorescence correlation
spectroscopy (FCS) [30] are widely used techniques for non-invasively obtaining information
on the key biophysical properties of biomolecules. Specifically, by correlating the fluctuations
in scattered (DLS) or fluorescent (FCS) signals over time, these techniques yield information
on the diffusional movement of molecules, which in turn provides insight into their hydrody-
namic radii. Both of these techniques have been used widely for sizing and characterising
homogeneous biomolecular samples, including proteins and their complexes [31–34]. Their
direct application to analysing heterogenous biomolecular samples, however, has remained
limited. The latter objective could be achieved by deconvoluting the observed fluorescence or
scattering traces, which is an ill-posed inverse problem [35]. In the case of DLS, accurate
sizing has been further challenged by the fact the intensity of scattered light is proportional to
the sixth power of particle size, which results in the presence of larger species masking signals
from smaller ones [29]. Moreover, DLS often requires samples at concentrations exceeding the
biologically relevant range [16]. For the characterisation of heterogenous samples, a micron
scale diffusional sizing approach based on tracking the movement of molecules both in space
and time was recently described [36]. Using such a two-dimensional tracking strategy, the
accessible information content was increased and, thus, the deconvolution capability of the
method enhanced in comparison to prevoiusly described in-solution sizing approaches. Its
performance, however, was nevertheless observed to become limited when the analytes did
not exhibit a few fold difference in their sizes, which in biological mixtures occurs only for
carefully chosen specimens [16, 37, 38].
Another type of in-solution protein analysis method involves spectroscopic characterisa-
tion. Indeed, spectral signatures of proteins can yield a myriad of information about the
positioning of atoms within a protein and, thereby, about their structure. In this con-
text, nuclear magnetic resonance spectroscopy (NMR) has been used to obtain accurate
predictions about the structure of proteins directly in solution and has been applied for
characterising samples that cannot be crystallised straightforwardly as is required for X-ray
crystallography [39]. Other spectroscopy based approaches, such as Fourier-transform infrared
spectroscopy (FTIR) [41, 42] and far-UV circular dichroism spectroscopy (CD) [43] do not
resolve the structure of proteins but can be used for effectively examining the secondary
structures of proteins and specifically, for detecting the presence of features, such as α-helices,
random coils and β-sheets. These approaches have been applied very widely for obtaining













Fig. 1.1 Commonly used protein characterisation tools and their characteristic features.
In this thesis we focus on the development of methods that enable protein behaviour
to studied on rapid timescales and under conditions that closely resemble physiological
environments.
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As all the aforementioned in-solution characterisation approaches work the best on homo-
geneous proteins samples, when heterogeneous mixtures of proteins are to studied, these
approaches are usually coupled to an upstream separation process, so that each component
or fraction in the mixtures could be analysed sequentially. While it would be, in principle,
desirable to perform this separation process also directly in solution and on a similarly rapid
timescale (Figure 1.1), a fundamental challenge associated with performing protein or any
other type of biomolecular analysis directly in solution is the tendency of diffusion and random
motion to oppose orderly separation and analysis. It is conventional, therefore, to perform
protein separation step through the integration of physical matrices that keep molecules of
similar sizes together. Indeed, chromatography based approaches, including various forms of
gel electrophoresis (e.g. agarose and polyacrylamide gel electrophoresis (PAGE)) and column
chromatography (e.g. size exclusion or ion-exchange chromatography), have been at the centre
of protein purification and analysis for decades and they can be performed as one-dimensional
or as two-dimensional separation processes. The separated species are subsequently charac-
terised either through a biochemical method, such as an immunoassay (Western blot) or a
biophysical characterisation process, such as light scattering. In this context, SEC-MALS
(size exclusion chromatography with multi-angle light scattering) has been actively used to ob-
tain a unique insight into the polydispersity of specific types of biomolecular mixtures [44, 45].
An alternative strategy to working with heterogeneous mixtures of proteins involves trans-
ferring the sample into gaseous phase, as is the case for mass spectrometry based analysis.
Such a strategy allows separating the formed ions based on their mass-to-charge ratio to
detect the components and infer their charges sequentially. Mass-spectrometry based analysis
approaches have for many decades yielded extremely high resolution information on the
molecular weights of biomolecules and have through this capability extensively advanced our
understanding of protein based systems [46, 47]. Its more recent versions, such as tandem
mass spectrometry (MS/MS) have enabled the quaternary structure and topology of various
protein complexes to be elucidated [48, 49]. Mass-spectrometry is often coupled to upstream
separation processes in order to simplify the complexity of the sample prior analysis [50, 51].
This reduction in complexity has been achieved through integrating it with chromatography
based approaches, such as liquid chromatography (LC-MS), or through gas-phase based ion
mobility spectrometry (IMS-MS) and have thereby enabled polydisperse mixtures of pro-
teins to be characterised at resolutions unachievable with any other protein characterisation
method [52, 53]. It is important to note that while the recent decades have seen extensive
research into the approaches how to best ionise the proteins and their complexes in particular
in a manner where they remain as close to their in-solution state as possible and these
efforts have led to the emergence of a term “native mass-spectrometry” [54], it is challeng-
ing to be fully certain whether the ionised sample fully corresponds its biological solution state.
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An additional set of techniques have been developed and used for specifically probing inter-
actions between proteins. In this context, surface plasmon resonance (SPR) measurements
have been employed across a variety of biological research fields to determine the binding
affinities between proteins and their molecular binding partners [55, 56]. Notably, a sys-
tematic comparison of binding affinity measurements has revealed that SPR measurements
are frequently reporting considerably lower binding affinities that gas-phase and in-solution
measurements [57]. It has been hypothesised to be the use of a dextran matrix involved
in the immobilisation step that contributes to this difference through a low affinity bind-
ing of the target protein to the dextran [58]. A number of other label-free surface based
and surface-free techniques have been developed to overcome this limitation. In particular,
bio-layer interferometry (BIL) based measurements have been shown to yield high quality
data on the strength of various protein-ligand interactions and have offered the possibility to
perform high-throughput screening studies [59–61]. Isothermal titration calorimetry (ITC)
and microscale thermophoresis (MST) have been used to probe protein interactions directly in
solution in an immobilisation-free manner [62]. While the former approach has traditionally
required relatively large sample sizes and a relatively long measurement timescale, which
has limits its applications, the latter approach has been developed and commercialised only
relatively recently [63] and has already been actively used for probing a wide variety of
biomolecular systems [62, 64, 65].
Last but not least, some of the most valuable and frequently used protein approaches involve
the introduction of chemical specificity to the analysis through the use of affinity reagents,
such as antibodies or aptamers. Specifically, enzyme-linked immunosorbent assays [66, 67],
Western blots [68–70] and proximity extension and ligation assays [71, 72] are all frequently
used molecular biology tools when highly heterogenous mixtures of proteins, including cell
lysates, are to be analysed. However, in contrast to approaches described earlier in this
Section, their use is restricted to the cases where suitable affinity reagents are available.
Moreover, such probe-based approaches do not permit explorative studies and detection
of hitherto unknown molecules but permit the identification of only pre-defined targets or
complexes. Notably, approaches relying on chemical specificity always result in a certain
degree of cross-reactivity and hence, similarly, yield best results if they are performed in
combination with tools that facilitate physical separation [73].
In summary, the majority of in-solution protein analysis approaches used today are work best
when homogeneous protein samples are used and usually address the problem of probing
heterogenous mixtures through the integration of a matrix aided separation process. While
this matrix aided separation process effectively fractionates molecules according to their
biophysical or biochemical properties, the presence of such matrices can affect the relative
strength of interactions and result in a preferential disassembly of selected complexes and,
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ultimately, in a bias in the observed results [74]. Moreover, its use prevents the examination
of samples that exhibit significant size variations, such as heterogeneous mixtures of proteins
and their self-assembled species, because the larger complexes present in such mixtures
obstruct the matrix pores. Last but not least, such matrix based separation approaches
usually operate on the timescale of hours with even when simplest one-dimensional separation
processes lasting for close to an hour. This long analysis time scale restricts the use of
such matrix aided systems to only slowly evolving systems. In the work described in this
thesis, I have focussed on the development of platforms that would enable the analysis of
heterogeneous samples directly in solution and on rapid time-scales (Figure 1.1). These
features make it possible to probe dynamic biomolecular interactions in solution and open up
the possibility to study biologically relevant interactions between biomolecules under their
fully native conditions.
1.3 Micron scale platforms for probing cells
In biological organisms, a significant fraction of proteins exert their function inside cells and
even those that do not, are at the first instance, synthesised inside cells. While in vitro
studies provide an effective route for probing the behaviour of proteins under well-controlled
conditions, it is of utmost importance to in parallel develop and apply methods that enable
probing protein behaviour inside cells.
Micron scale analysis platforms have been shown to serve as an attractive strategy for studying
the behaviour of cells. In particular, the possibility to exert tight spatial control over fluid
movement has been exploited to expose cells to various external stimuli and examine their
effect on cellular growth in a much more controllable and reproducible fashion than has
been possible on macroscale platforms [75, 76]. These strategies have also been used for
developing organ-on-chip platforms for screening the effect of various drug candidates in
conditions closely mimicking in vivo environments [77–79]. While these approaches focus on
studying the collective behaviour of a variety of cells, the possibility to tightly control fluid
behaviour micron scale platform has also been put into action for specifically probing the
interactions between two neighbouring cells. Such experiments have been used to develop and
understanding the molecular mechanisms that underlie cell-to-cell communication [76, 80].
In parallel, microfluidic devices have been used for separating and fractionating cells and
cellular organelles as well as for spatially positioning them, which has been achieved mainly
through the application of electrophoretic and dielectrophoretic fields [81, 82].
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Last but not least, micron scale platforms and the possibility to encapsulate individual cells
into individual compartments as will be highlighted in more detail in Section 1.4, has set the
basis for performing high-throughput single cell studies. Indeed, cells are the fundamental
units of living cells with their behaviour having been observed to differ substantially between
cells. Micron scale channels have been for many decades used to perform high-throughput
sorting of cells through approaches such as fluorescence activated cell sorting (FACS) that
rely on a cellular biochemical pathway emitting a fluorescent signal indicative of the property
according to which the cells are to be screened and sorted. More recently, such high-
throughput single cell analysis approaches have been extended to probing the transcriptomic
content of individual cells and have thereby yielded unique insight into the most fundamental
biological questions in areas ranging from immunology to developmental biology [83–91].
These approaches have been to some degree extended to studying other biological molecules
in cells, such as proteins or metabolites but the methods developed to date have remained
limited in their throughput or in their multiplexing capability, allowing only a small number
of targets to be probed simultaneously. I will discuss these developed approaches and their
applications and limitations in more detail at the start of Chapter 6.
1.4 Micron scale approaches for analysing biologi-
cal systems
Fluid behaviour on the micron scale differs substantially from the macroscale environment.
One of the key differences between the behaviour of fluids at these two length scales is
captured by the ratio of the inertial to viscous forces, also called the Reynolds number:




where ρ and η are the density and the dynamic viscosity of the medium, respectively, u is
velocity of the fluid and d is the characteristic length scale of the fluid movement. In the
case of fluid flow inside micron scale channels, this characteristic length scale is the hydraulic
diameter dH of the channel.
In the work described in this thesis, the channel dimensions ranged between 1 and 2000 µm
and the flow rates between 1 and 2000 µL h−1. Under these conditions, the Reynolds number
was estimated to be below Re ∼ 10−1. As a result, the inertial movement of molecules
was suppressed and molecular transport was defined by diffusion, which can be precisely
controlled and modelled [92, 93]. This feature was a key factor to the strategies for probing
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the properties of proteins and protein mixtures and obtaining highly accurate quantitative
insight to biological systems that I will be presenting in the following chapters.
Whereas all the devices described, developed and applied in this thesis involved operation
under low Reynolds number conditions, I used the arising ability to tightly control the
movement of fluids to serve a range of different goals. Namely, in some of the work, I aimed
to keep analyte molecules confined. I achieved this objective by designing the systems such
that the relative residence times of fluids was slow in comparison to the diffusional movement
of the molecules therein (Figure 1.2a, i). This relative extent of diffusion could be captured






which was here defined as the ratio of the diffusive time scale in the y-direction and the
advective time scale in the x-direction (Figure 1.2). In other studies, my objective was to
generate non-physical semipermeable membranes (Figure 1.2a, ii) that could be crossed by
selected species. I realised this goal by ensuring that the Péclet number for one species was
significantly larger than for another. Last but not least, when my intention was to obtain
quantitative information based on the diffusional movement of molecules, I ensured that the
Péclet number of the analyte molecules was of an intermediate value, so that the extent of
diffusional movement could be used for estimating diffusion coefficients of the analytes and
thereby their hydrodynamic radii.
In addition to opening up the possibility of precisely controlling fluid behaviour and thereby
maintaining the localisation of analyte molecules, the use of micron scale channels introduces
additional attractive features for working with biological samples, such as the reduced sample
consumption and the high recovery rate that such platforms afford [94–99]. Moreover, such
platforms permit building tandem devices and combining multiple processes onto a single
chip [100, 101], thereby both speeding up the analysis process and automating it. Whereas the
first micron scale devices were fabricated in glass and silicon already many decades ago [102],
it was during the past decade that fast and replicable approaches emerged for generating
such devices out from optically transparent and easily mouldable soft polymers [103, 104].
These rapid prototyping approaches have had of central contribution to the increasing use
of micron scale devices in biological and biomedical research [96, 82, 105]. In particular, it
has to a very large degree been the polydimethylsiloxane (PDMS) based fabrication process
through its highly reproducible yet rapid prototyping has set the basis for this advancement.
An additional attractive feature associated with the use of micron scale channels in the
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Fig. 1.2 Controlling fluid behaviour on the micron scale. (a) In micron scale channels,
due to the absence of turbulent mixing, the movement of molecules is governed by
their diffusion. This behaviour can be exploited (i) to prevent molecules from mixing
(high Péclet number conditions) or (ii) to construct non-physical membranes that
can be crossed selectively only by the fastest diffusing species (molecules in aqueous
solution 2; low Péclet number conditions). (b) Micron scale channels can be used to
produce miniature water-in-oil droplets that can serve as individual reactions vessels
for compartmentalising biochemical reactions or biophysical processes.
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uniform volumes (Figure 1.2b). Such microdroplets allow a large number of independent
reactions to be monitored in parallel in volumes which are several orders of magnitude smaller
than in conventional bulk assays [106–108]. The arising possibility to perform analysis at
high throughputs has proven extremely valuable for analysing individual cells and detecting
heterogeneities within cellular samples that are masked when the analysis is performed in
bulk [83–91]. In addition to parallelised screening, volume confinement has been exploited to
observe stochastic and often rare events, such as those taking part when proteins self-assemble
in order to obtain statistic information on their occurrence [109, 110]. Indeed, self-assembly
process is governed by a series of microscopic steps, which vary in relative importance
between systems of different sizes, with the more dominant steps masking the rarer ones in
non-compartmentalised bulk scale assays. The use of micron scale structures, however, opens
up the possibility to track of such rarer events as well [111, 112].
1.5 Summary of the thesis
In this thesis, I discuss the development and application of new tools for probing the behaviour
of proteins and protein interactions first in vitro and then inside cells using micron scale
fabrication and flow engineering approaches.
The first half of the thesis focuses on in vitro analysis platforms. Specifically, in Chapter 3, I
will discuss the development of a microfluidic device that facilitates high-throughput mea-
surements on protein self-assembly in a label-free environment. I will outline and illustrate
a series of advantages that this measurement strategy provides over conventional manual
approaches. In Chapter 4, I will focus on the development of a rapid separation platform
and demonstrate its application for separating and quantitatively characterising biomolecular
species and their complexes. I will describe a series of technical and conceptual advances
that led to the development of this platform and use the devices for detecting and visualising
interactions between proteins and protein complexes. In Chapter 5, I will further demonstrate
the possibility to combine this separation platform with direct on-chip analysis. These devices
enabled me to obtain multidimensional data on biological mixtures and to characterise
biological samples on resolutions not accessible by current state-of-the art in-solution analysis
approaches.
I will proceed by describing the use of micron scale flow engineering approaches for un-
derstanding protein behaviour inside cells. In Chapter 6, I will describe a general-purpose
strategy for detecting intracellular proteins inside single cells in a high-throughput manner.
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Unlike previously described approaches, this platform offers significantly greater multiplexing
extent than existing single cell protein analysis platforms. Finally, in Chapter 7, I will focus
on a specific application of cellular biophysics. I will characterise cellular electrical responses
and further develop solar panels that use biological photosynthetic organisms as catalysts.
Chapter 2
Materials and Methods
2.1 Preparation of microfluidic devices
2.1.1 Fabrication of replica master moulds
Singlelayer (SL) replica master moulds were fabricated through standard lithography ap-
proaches [103, 113] as illustrated in Figure 2.1. Briefly, a thin layer of SU-8 photoresist
(MicroChem, Massachusetts USA) was spinned onto a three inch polished silicon wafer
(MicroChemicals, Germany) using a spin-coater (Specialty Coating Systems, Indiana USA;
Figure 2.1a). The grade of the photoresist (SU-8 3010, SU-8 3025, SU-8 3050) and the
rotational speeds and times were varied according to the manufacturer’s guidelines to achieve
a desired feature height varying between 5 and 100 µm as outlined in the specific sections.
To selectively cross-link the photoresist in the areas were microfluidic channels were to
appear, the wafer was exposed to custom-built UV-LED based apparatus [114] through an
acetate transparency (Figure 2.1b). The structures on the transparency had been designed
using AutoCAD software (Autodesk Education, California USA) and were printed by Micro
Lithography Services Ltd, UK. All the uncross-linked photoresist was then removed by im-
mersing the wafer in propylene glycol monomethyl ether acetate developer solution (PGME;
Sigma, UK), followed by rinsing the wafer with isopropanol (IPA) and blow-drying it with
pressurised nitrogen. This PGME development step (Figure 2.1c) resulted in the production
of an inverse mould master with raised patterns corresponding to the channels in the final
device (Figure 2.1d). The precise feature heights on the master were verified by profilometer
(Dektak, Bruker) and were usually found to be within a 10% margin of the desired height.
The master moulds were converted into patterned PDMS chips and ultimately, to microfluidic
devices as described in Section 2.1.2.
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Fig. 2.1 Fabrication of master moulds for reproducible production of polymer-based
microscale devices. (a) A thin layer (5 − 100µm) of photoresist is spinned onto a
smooth silicon wafer and (b) covered with a photomask to expose selected areas of the
wafer to UV-light and cross-link the photoresist in these areas. (c) The non cross-linked
photoresist is then dissolved away in a developer solution (d) to yield a patterned
















Fig. 2.2 Fabrication of PDMS microfluidic devices. (a) The replica mould (Figure 2.1)
is casted in PDMS (b) to yield micropatterned PDMS surfaces. (c) Small sections
of the PDMS are then punched off to introduce orifices for fluid inlets and outlets.
(d) Finally, the patterned PDMS surfaces were irreversibly sealed with or glass (visible
wavelength excitation) or a quartz (UV wavelength excitation) microscope slide or
coverslip.
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The fabrication of multilayer (ML) replica mould involved two subsequent UV-lithography
steps each performed analogously to the singlelayer lithography process described in the
previous section. After the first layer of structures had been developed, a new layer of SU-8
was spinned onto the wafer and exposed to UV light through a second lithography mask
including the relevant structures. The alignment of the structures on this second mask with
the already existing features was ensured with the inclusion of alignment markers on the
edges of both of the masks. The features on the thinner layer were always produced first
to minimise the obstructive effect on the formation of a uniform layer during the second
photoresist spinning step. As for the SL mould, the heights of the structures on both of the
layers were determined by a profilometer and were usually found to be within a 10% margin
of the desired height.
2.1.2 Fabrication of 2D PDMS devices
To prepare polydimethylsiloxane (PDMS) microfluidic devices, single or multilayer replica
moulds were casted in PDMS and cured, after which their surfaces were sealed to yield
microscale channels (Figure 2.2). Specifically, PDMS elastomer and curing agent (Sylgard®
184, Dow Corning, Onecall, UK) were mixed in 10 : 1 ratio by weight, poured into the
negative patterns of the master mould (Figure 2.2a) and cured for 90 minutes at 65◦C, after
any air bubbles had been removed in a desiccator. For experiments that involved fluorescent
detection, 0.2% w/w, of carbon powder was included in the PDMS mixture to suppress the
background fluorescence arising from the autofluorescence of PDMS.
After curing, the PDMS was removed from the master and orifices for fluidic ports introduced
(Figure 2.2b-c) using a 0.75 mm biopsy puncher (World Precision Instruments, Florida
USA). The patterned surfaces of the PDMS slabs were then cleaned by Scotch Magic™ Tape,
following which the slabs were placed in a 50 mL Falcon tube containing IPA and sonicated
in a water bath for 5 minutes to yield as clean surfaces as possible. The slabs were allowed
to dry completely and bonded to either a glass (ThermoFisher Scientific or a quartz (Alfa
Aesar) microscope slide or coverslip to yield closed channels (Figure 2.2d). The bonding
was achieved by activating both the PDMS and the glass or the quartz surface with oxygen
plasma (Electronic Diener Femto, 40% power for 15 seconds). Immediatelly prior to the
experiments, the devices were exposed to an additional plasma oxidation step (80% power
for 500 seconds) to form silanol groups on the PDMS surface and render channel surfaces
more hydrophilic [115] and avoid protein or protein fibril samples adhering to the PDMS
walls of the device.









Fig. 2.3 Fabrication of 3D PDMS microfluidic devices. Two polymer slabs, one produced
from a single layer and the other one from a multilayer replica mould are bonded
together to yield 3D devices.
2.1.3 Fabrication of 3D PDMS devices
Three-dimensional (3D) PDMS devices were generated by plasma bonding two individual
PDMS chips to each other (2.3). Specifically, one of the two chips involved the casting of a
ML replica master and the other one a SL replica master in PDMS through the protocol
described in Section 2.1.2. To achieve an alignment accuracy of the order of micrometers,
water droplets were sprayed onto the patterned surfaces of the two chips after the surfaces
had been activated by oxygen plasma. This procedure prevented their instantaneous sealing
and allowed adjusting their relative positions under a stereomicroscope before a seal between
the chips was formed. The aligned chips were then placed in an oven at 65 ◦C for one hour to
allow the water to evaporate and the covalent bonding to take place. This procedure enabled
producing injection orifices in the centre of the microfluidic channels as was desired for the
devices used in Chapters 3 and 4.
2.1.4 Controlling fluid flow in microscale channels
Fluid flow into the devices was controlled using neMESYS syringe pumps (Cetoni GmbH). The
solutions were injected using syringes (Hamilton™) that were connected to the microfluidic
access ports using polyethylene tubing (Smiths Medical; 800/100/120) and 27-gauge needles.
Depending on the particular application, the flow in the devices was controlled either by
injecting the fluids into the devices or alternatively, by placing fluid reservoirs to the device
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inlets and withdrawing fluid from the device outlet. In the latter case, the flow rates of the
fluids in the channels were determined by the hydraulic resistances of the channels, RHD.
Under the laminar flow conditions, fluid flow rate Q is linearly proportional to the applied
pressure difference ∆P and inversely proportional to the hydraulic resistance RHD of the
channel
∆P = RHD · Q (2.1)
This relationship allowed me to predict the flow rates in networks of microscale channels by
applying requiring current balance and equipotentiality criteria at each node, similarly to
how Kirchoff’s Laws are used for predicting currents in a network of resistors.
2.2 Methods specific to protein self-assembly mea-
surements
2.2.1 Microwell plate protein aggregation assays
Throughout the experiments, bovine insulin (Sera Laboratories GEM-700-112-P; used without
further purification) was used as a model system and it was aggregated in 50 mM NaCl at
pH 2.0 (adjusted with HCl) unless specified otherwise. In order to accelerate the aggregation
process, 5% of the initial insulin was added in the form of pre-formed seeded fibrils with
the rest of the protein being in its monomeric form. The pre-formed fibrils were generated
by incubating 10 mg mL−1 insulin (pH 2.0, no NaCl) for 24 hours at 60 ◦C. Before adding
the seeds to the aggregation mixture, they were sonicated (3 times for 5 minutes, Bandelin
Sonopuls HD2070, 8 W, VS 70 probe) to fragment the fibrils and increase the number of free
ends available for aggregation [116].
To track the aggregation process, Thioflavin T (ThT) was added to a final concentration
of 30 µM either at the start of the aggregation process (in situ assays) or right before the
fluorescence reading was taken (ex situ assays). In both cases the fluorescence intensities
were recorded on a microplate reader (BMG LabTech, FLUOstar) using a 96 well half-area
black bottom polystyrene plates (Corning, product #3881) with 100 µL sample in each well.
The multiwell plate was sealed with an aluminum tape (Corning, product #6570) to reduce
any evaporation of the fluid from the wells.
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2.3 Methods specific to protein on-chip separation
and analysis
2.3.1 Preparation of protein samples
Unless otherwise stated, the proteins were purchased from Sigma-Aldrich and used without
further purification. The experiments were performed with the proteins dissolved in 10 mM
sodium phosphate buffer at pH 7.4 and the buffer and protein solutions were filtered before
performing the experiment (EMD MilliporeTM, 0.22 µm).
The recombinant Amyloid-β 1-42 with an N-terminal methionine (hereafter abbreviated as
Aβ) was prepared by collaborators in the research group of prof. Sara Linse (Department of
Biochemistry and Structural Biology, University of Lund, Sweden). Briefly, the protein was
expressed in Escherichia coli from a PetSac plasmid [117] and the inclusion bodies dissolved
in 8 M urea, 10 mM Tris/HCl, 1 mM EDTA buffer (pH 8.5). The Aβ protein was then
isolated using ion exchange on diethylaminoethyl cellulose resin followed by two rounds of
size exclusion purification in 20 mM sodium phosphate, 0.2 mM EDTA buffer (pH 8.5) using
a Superdex 75 HR 26/600 column (GE Healthcare) and by one further round in 20 mM
sodium phosphate, 0.2 mM EDTA buffer (pH 8.0) using a Superdex 75 HR 10/300 column
(GE Healthcare). Before each round the peptide solution was lyophylised and dissolved
in 6 M Guanidinium chloride (GuHCl), 20 mM sodium phosphate buffer (pH 8.5) as de-
scribed previously [117, 118] .The final round of the purification process served to isolate the
pure Aβ monomer and it was performed right before the protein was used for the experiments.
C-terminal pro-SPC Brichos (hereafter called Brichos) was similarly prepared by collaborators
in the research group of prof. Sara Linse. In short, the protein was expressed in Escherichia
coli cells with thioredoxin and His6 tags as previously described [119] with the plasmid being
a gift from Jenny Presto and Jan Johansson, Karolinska Institute, Sweden. The inclusion
bodies suspended in 2 M urea, 20 mM Tris, 0.5 M NaCl, 5 mM imidazole buffer (pH 8.0),
following which the fusion protein was purified on a Ni2+-loaded HiTrap Chelating HP column
(GE Healthcare) and cleaved to release the thioredoxin and His6 tag, which was removed
using the same chelating column. The Brichos protein was then further purified via ion
exchange chromatography using salt gradient wash. The Brichos peak was collected and
dialysed against 20 mM sodium phosphate buffer (pH 7.4) and equimolar amount of amine
reactive Alexa488 (Life Technologies) added from a 5 mM stock dissolved in DMSO to label
the Brichos. The solution was incubated at room temperature in dark for one hour and any
unreacted dye was removed by gel filtration in 20 mM sodium phosphate, 0.2 mM EDTA
(pH 8.0).
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2.3.2 Label-free detection of proteins in the deep UV-wavelength
range
Proteins were visualised in their unlabelled forms using a custom-built inverted deep-UV
fluorescence microscope a described in detail in Ref.[114]. Briefly, the sample was illuminated
using a 30 mW 280 nm LED (Thorlabs) exploiting the intrinsic fluorescence of aromatic
residues of proteins in the deep-UV wavelength range. Briefly, the light was passed through
an aspherical lens of a focal length of 20 mm to get a nearly collimated beam and after this
onto a dichroic filter cube (280/20-25 nm excitation, 357/44-25 nm emission, 310 nm dichroic
beamsplitter). The reflected light from the dichroic mirror was focused onto the sample by
an infinity corrected UV objective lens (Thorlabs LMU-10X-UVB; numerical aperture of
NA=0.25) and the emitted light collected through the same objective, passed through the
emission filter and focused onto an EMCCD camera (Rolera EM-C2). All the used optics
were made out of fused silica to enable high transmission in the UV wavelength region.
2.4 Methods specific to detecting proteins in indi-
vidual cells
2.4.1 Preparation of DNA conjugated antibodies
The work described in Chapter 6, involved using protein kinase B as the protein target. The
protein was detected using protein kinase B antibody pair (PKB; Abcam Human AKT1
Matched Antibody Pair Kit; #ab219528) with the capture antibody conjugated to a DNA
sequence as described in this section and the biotinylated detector antibody conjugated to a
streptavidin bead as described in Section 2.4.3.
The capture antibody to be conjugated to a DNA sequence was first exchanged from its
storage buffer into a 100 mM pH 8.0 phosphate buffer using ZebaTM 7K MWCO Spin
Desalting Columns (#89882) following the manufacturer’s guidelines. Specifically, the storage
solution of the column was removed by spinning it at 1500 g for 1 minute, after which
it was washed 3 times with 300 µL buffer similarly at 1500 g for 1 minute. To exchange
the buffer, 100 µL of the antibody solution was placed on top of the resin bead and the
fractionate collected after centrifuging for 1 minute at 1500 g. The antibody concentration af-
ter the buffer exchange was determined by absorbance at 280 nm (BMG LabTech, FLUOstar).
To initiate the conjugation reaction, 2 mg of DBCO-PEG5-NHS Ester (Click Chemistry
Tools; #A102P-2) was dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich; #D8418) to a
final concentration of 100 µM and a fraction of it further diluted to 10 µM and distributed
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into 7 µL aliquots. The buffer exchanged antibody was then reacted in 1:47 molar ratio
with the DBCO-PEG5-NHS ester by mixing 94 µL of 13 µM antibody with 6 µL of 10 mM
DBCO-PEG5-NHS Ester. The mixture was incubated at room temperature for 30 minutes,
following which any unreacted DBCO-PEG5-NHS ester removed using the three ZebaTM
7K MWCO columns each washed with PBS buffer as described in the previous paragraph.
Finally, the DBCO activated antibody was reacted with an azide modified DNA (Integrated
DNA Technologies; HLPC purified) in 1:4 molar ratio by mixing 50 µL of 10 µM antibody
with 25 µL of 100 µM azide-DNA. The mixture was incubated overnight at 4◦C.
To examine the extent of the conjugation reaction, the mixture was analysed on a NuPAGETM
4-12% Bis-Tris protein gels (ThermoFisher Scientific; # NP0322BOX) by loading around
2 µg of protein into each well and running it for 35 minutes at 180 V. The gel was stained
with InstantBlueTM (Coomassie) protein stain (Expedeon; #ISB1L).
2.4.2 Cell growth and barcoding the proteomic material
Human SH-SY5Y neuroblastoma cells (A.T.C.C.) were kindly cultured by Nina Kloss (Centre
for Misfolding Diseases, Department of Chemistry, University of Cambridge) in Dulbecco’s
Modified Eagle Medium (DMEM) as described previously [120]. Before the experiments,
the cells were centrifuged at 1000 rpm for 3 minutes and resuspended in PBS to yield a
concentration of 4 · 107 cells mL−1 - this concentration was estimated to result in an average
concentration of one cell per one microdroplet during their encapsulation into droplets.
The cells were mixed on-chip in 1:1 ratio with lysis buffer that also included barcoded
capture antibodies for protein kinase B prepared as described in Section 2.4.1 and acrydite
modified cell barcode DNA sequences(Table 6.1). Specifically, the lysis bufffer was prepared
by mixing 300 µL of 20% Ficoll PM-400 (Sigma-Aldrich; #F5415), 10 µL of 20% Sarkosyl
(Sigma-Aldich; N-Lauroylsarcosine sodium salt solution; #L7414), 40 µL of 0.5 M EDTA
pH 8.0 (Sigma-Aldrich; #03690), 100 µL of 2 M Tris HCl pH 7.5, 100 µL of 2 M Tris HCl pH
7.5 and 50 µL of 1 M Dithiothreitol (DTT; ThermoFisher Scientific; #P2325). The protein
kinase B (PKB) specific capture antibody was diluted into this lysis buffer at 2 µg mL−1 as
suggested in the manufacturer’s protocol and the cell barcode DNA to a concentration of
50 nM. The buffer was then diluted to 1 mL with deionised water.
The co-encapsulation was performed using a microfluidic chip with an on-chip mixing module
(Figure 6.2a). The device was fabricated in PDMS to a height of 100 µm as described in
Section 2.1.2. The flow rates of both the cells suspended in PBS and the lysis buffer with
the barcoding sequences and barcoded antibodies were set to 150 µL h−1 and the flow rate
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of the surfactant and the oil - 2% w/v FluoroSurfactantTM (#008; Ran Biotechnologies) in
FC-40 (FluorinertTM; 3MTM) - to 800 µL h−1. After a stable droplet formation had been
established, 150 µL of the emulsion product was collected into a 200 µL PCR tube and left at
4◦ for 30 minutes for the cells to lyse and hybridisation between the two DNA strands to occur.
Following the cell lysis and barcoding in droplets, the emulsion droplets was de-emulsified by
first removing the oil from the tube and then adding 2 µL of neat perfluorooctanol (PFO)
per every 10 µL of emulsion. The contents were mixed thoroughly. After phase separation
had established, any oil was removed and fresh PFO added. This process was repeated 3-5
times until no emulsion droplets were observed. Finally, the aqueous phase was carefully
transferred into a clean PCR tube - only around the top 80% of the aqueous product was
taken to ensure that it is completely free of oil.
2.4.3 Purification of the DNA library
To prepare antibody conjugated magnetic beads for purifying the DNA library, 50 µL of
10 mg mL−1 of the streptavidin coated M-280 DynabeadTM suspension (ThermoFisher Sci-
entific; #11205D) was mixed with 5 µL of 0.25 mg mL−1 of the biotinylated PKB detector
antibody (Section 2.4.1), and diluted to 200 µL with PBS. The mixture was incubated at
room temperature for 20 minutes under continuous stirring and washed four times with
200 µL PBS supplemented with 0.1% v/v bovine serum albumin (BSA). The washed product
was dissolved in 200 µL of PBS.
To purify the de-emulsified product including both the DNA sequences of PKB bound and
non-bound antibodies (Section 6.3.2), 20 µL of this mixture was mixed with 1.6 µL of the
magnetic bead conjugated detector antibody stock solution to result a final concentration of
0.5 µg mL−1 of the detector antibody as suggested by the manufacturer. The mixture was
left to incubate at room temperature for 30 minutes, and washed four times with 50 µL PBS
supplemented with 0.1% v/v BSA and 0.01% v/v Tween® 20 (Sigma-Aldrich). The product
was resuspended in 20 µL of PBS including 0.1% sodium dodecyl sulphate (SDS) and boiled
at 95◦C for 3 minutes to cleave the biotin streptavidin bond and release the DNA sequences
from the magnetic beads.
2.4.4 Amplification of the DNA library
The PCR reaction was performed by mixing 10 µL of 2X Taq DNA Polymerase master mix
(ThermoFisher Scientific; #K0171) with 0.5 µL of 10µM forward (Fwd) and reverse (Rev)
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primers (Table 6.1) and 2 µL of the test sample, and diluted to 20 µL using deionised water.
The PCR reaction mixture was amplified by first heating it to 95◦ for 2 mins for initial
deannealing, then running 35 melting, primer annealing and extension cycles at 95◦C (20 s),
62◦C (30 s) and 68◦C (30 s), respectively and finally, performing the final extension at 72◦C
for 3 mins. The amplification process was followed in real time using a QuantStudio 3 qPCR
instrument (ThermoFisher Scientific).
2.5 Methods specific to measurements in biological
photovoltaics
2.5.1 Culturing of the Synechocystis sp. PCC6803 cells
Wild-type Synechocystis sp. PCC6803 and its recombinant strains were routinely cultured
in BG-11 medium (Gibco®) supplemented with 10 mM NaHCO3 and maintained in sterile
conditions at 30 ± 2 ◦C under continuous moderate light of 40 µmol photons m−2 s−1 and
shaking at 160 rpm [121, 122]. Suspensions including higher cell concentrations were formed
by centrifuging the original cell culture (5000 rpm for 3 minutes) and re-suspending the
supernatant in fresh growth medium. The concentration of chlorophyll in cell cultures was
determined spectrophotometrically from the optical density values at 680 nm and 750 nm
as described previously [123]. Mutant strains of Synechocystis sp. PCC6803 were generated
by Dr. David Lea-Smith (Department of Biochemistry, University of Cambridge) with the
details on the experimental steps outlined in Appendix 1.
2.5.2 Integration of electronic components with the BPV
The anode of the device was fabricated as a long electrode spanning the full length of
the device. For this purpose, an array of pillars was fabricated between the fluidic BPV
chamber and the channel were the electrode was to appear. Such a design strategy allowed
for the insertion of molten anode material (Indalloy 19 (51% In, 32.5% Bi, 16.5% In), Conro
Electronics), which solidified upon removal from the hot-plate, yielding self-aligned electrode
walls as has been previously described [124].
The cathode of the device comprised of a point electrode at the end of the channel. It was
produced by inserting a strip of 100 µm diameter platinum wire (AlfaAesar) or platinum
plated wire (GoodFellow) through polyethylene tubing (Smiths Medical; 800/100/120) sealed
by an epoxy glue from both ends with approximately 1 mm metal left outside the tubing.
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This allowed direct contact of the metal with the fluids flowing in the BPV when placing
the cathode in the BPV via its designated access port. Copper wires were soldered to both
the cathode and the anode, and alligator clamps were used to connect the electrodes to the
potentiometer to characterise the performance of the device.
2.5.3 BPV operation and characterisation
The “charging unit” of the BPV was illuminated under red light (Maplin Strip RGB kit)
with its intensity of the incident light measured using a quantum sensor uniformly detecting
photosynthetically active radiation between 400 and 700 nm (Skye Instruments). The
performance of the BPV system was characterised by applying a linear voltage sweep across
the positive and negative terminals of the power delivery unit using a potentiostat (Autolab
PGSTAT 12). After a stable terminal voltage value had been reached, the voltage was varied
from 800 mV to 0 mV at a rate of 2 mV s−1 and the current output recorded at each voltage.
The device was kept at 22 ± 2 ◦C throughout the characterisation process. In order to
accurately characterise the biological power output the measurements were first performed
in biologically non-loaded and then in biologically loaded form. All the power outputs were




Automated high throughput ex situ
measurements on protein
self-assembly
This chapter is based on the following publication:
Saar KL et al., Biophysical Journal, 110(3), 555-560, 2016.
3.1 Motivation
The process of protein self-assembly is of central importance for both normal [125] and
aberrant biology [4–7], as well as for the development of novel materials for nanotechnol-
ogy [126, 127, 111]. Specifically, it has been brought into connection with the onset of over a
few dozen diseases, including those of rapidly increasing prevalence, such as the Alzheimer’s
and Parkinson’s disorders and type II diabetes [4, 5, 128–130]. Despite the well established
connection between the protein amyloid formation process and the onset of these diseases,
the molecular mechanisms that underlie the onset of these conditions have been challenging
to establish [128, 129, 131–135]. This difficulty has in part originated from the challenges
associated with reliably probing the protein aggregation process in vitro.
One of the most frequently employed techniques for monitoring protein aggregation in vitro
involves the use of extrinsic amyloidophilic probes. Upon binding to β-sheet rich fibrils, such
dyes exhibit changes in their fluorescent spectra, which can be recorded externally with a spec-
trophotometer, thereby allowing the β-sheet rich amyloid aggregates to be detected and their
amount to be quantified. However, many of the frequently used probes, such as Congo red or
Thioflavin S, have a propensity to influence protein misfolding and aggregation processes
and do not permit reliable extraction of quantitative information about the concentration of
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Fig. 3.1 In situ assays (top) are straightforward to perform but they require direct
introduction of probe molecules into the assays. Ex situ assays (bottom), where at
specific time points small samples of an aggregating protein solution are extracted and
diluted into buffered dye, eliminate any undesired interference of the probe molecules
on the aggregation process. However, conventional ex situ measurements are labour
intensive to perform and perturb the reaction mixture.
aggregated material present [136–138]. Indeed, some very effective “beta-breaker” molecules
that inhibit protein aggregation have structures that are modelled on amyloidophilic dyes [139–
142]. Other probes, such as thioflavin T (ThT) have been suggested not to exhibit any or
exhibit only minimal interference with the aggregation process [138, 143]. However, the exact
mechanism of their binding to fibrils is still unclear [138, 142, 144] and conventional in situ
assays (Figure 3.1, top) where the marker molecules are present throughout the reaction,
commonly yield signals which are not directly proportional to the concentration of aggregates
and are hence challenging to interpret in a quantitative manner [145, 146]. Moreover, the
fluorescence properties of fluorescent probes, especially their quantum yields are affected by
extrinsic conditions [136]. Therefore, since the readouts take place directly within the reaction
medium, the measured signals are highly dependent on the surrounding environment, making
it challenging to compare the aggregation process under different experimental conditions,
such as the ionic strength or pH of the aggregation environment.
These drawbacks can be effectively eliminated through the use of an ex situ measurement
strategy, where the probe molecules are not brought into contact with the reaction mixture
but rather with aliquots taken from the aggregation sample (Figure 3.1, bottom), thus
avoiding any interaction between the aggregating protein and the dye. In addition to allowing
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extracting quantitative information about the amount of aggregates present, the reaction and
measurement steps are spatially separated and chemically decoupled, making comparison
between aggregation reactions that take place in different environmental conditions possible.
Despite their advantages, ex situ measurement strategies possess different drawbacks which
have limited their widespread adoption: they are laborious to perform as every time point
requires manual intervention and the reaction can be followed only at a limited number of
time points. Furthermore, the requirement to physically separate aliquots from the reaction
mixture implies the use of large physical volumes for the aggregating protein solution. Last
but not least, withdrawing aliquots often results in agitation of the reaction mixture and
can have a significant effect on the aggregation process if the process is to be studied under
quiescent conditions. In the experiments described in this chapter, I address the limitations
of conventional ex situ measurements and design and demonstrate devices that eliminate the
need for physical aliquot extraction and instead allow for ex situ aggregation measurements
to be performed in an automated and high throughput manner.
3.2 An automated high throughput ex situ mea-
surement strategy
I set out to design and fabricate devices that would automate the manual aliquot taking
process implicated in conventional ex situ measurements yet retain all of its advantages -
most notably, the spatial separation and the resulting chemical decoupling of the aggregation
process and the fluorescent measurement - while offering additional benefits of eliminating
the need for manual aliquot taking, allowing tight control over the reaction time of the dye
with the aggregate species, avoiding agitation of the aggregation mixture and providing the
capability to follow the aggregation process in real time.
My devised design involved a two inlet system (Figure 3.2) where a label-free aggregating
protein sample (marked green) and buffered dye are continuously transferred to a measurement
system. Upon entry into the mixing and labelling area (marked yellow), the buffered dye
mixed with the protein sample. The time period that it took for the fluids to move between
the point where the protein and the dye first met and where the fluorescence readings were
recorded was short (seconds) compared to that of most protein self-assembly processes (hours).
Hence, effectively no further aggregation occurred in the presence of the probe molecules.
Moreover, the residence time, tres, between the points where the two streams of fluids first
met and where the fluorescence was recorded was designed to be longer than the time needed
for the ThT molecules to diffuse into the central protein stream. Specifically, the time and













Fig. 3.2 Device architecture for performing ex situ measurements on chip. When the
aggregating protein and the buffered dye streams mix, the probe molecules can start
diffusing into the protein stream and bind the protein fibrils. Inset: the measurement
is taken sufficiently downstream for all the protein stream to have become labelled.









where k is the Boltzmann constant, T is the temperature and η is the viscosity of the solution.
In the following chapters I show that this proposed strategy underlies a significant improve-
ment in terms of data throughput compared to manual ex situ assays, allowing hundreds of
individual measurements to be performed in real time and on a single aggregating protein
system.
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Fig. 3.3 Advantages of ex situ aggregation assays over in situ assays. (a) As opposed
to in situ aggregation assays (red circles), the fluorescence intensity in ex situ assays
(blue triangles) scales linearly with the aggregate concentration (R2 = 0.997). The
data points correspond to fluorescence signal at the aggregation end-point with the
aggregation occurring at pH 2.0 and NaCl concentration of 50 mM. (b) A similar
non-linear scaling between the end-point fluorescence intensity and the insulin fibril
concentration was observed in in situ assays in different aggregation environments
(50 mM and 100 mM NaCl, both at pH 2.0) and ThT concentrations (2 µM and 20 µM).
(c) When studying ex situ aggregation assays in a standard buffer (500 mM NaCl),
any effect from the aggregation buffer can be eliminated (blue triangles). Such spatial
and chemical decoupling is not possible in in situ assays (red circles). All the data
shown are an average of n = 3 repeats with the error bars corresponding to standard
deviations.
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3.3 Results
3.3.1 Microplate reader assays
I first evaluated the performance of in situ and ex situ assays in bulk scale experiments. To
this effect, a series of different concentrations of insulin was left to aggregate for 12 hours
following seeding the reaction (Materials and Methods, Section 2.2.1). The end-point fluores-
cence intensity at all the concentrations for both in situ and ex situ assays were recorded
and are shown in Figure 3.3a. The ex situ assays were observed to exhibit a linear scaling of
the end-point fluorescence intensity with the insulin concentration across the full range of
the protein concentrations analysed (blue triangles); by contrast, such simple linear scaling
was not detected in the in situ assays (red circles). I also examined the in situ aggregation
process of insulin in different reaction environments (50 mM and 100 mM NaCl, both at
pH 2.0) and dye concentrations (2 µM and 20 µM ThT) and noted that the lack of such
a scaling relationship is a more general trend occurring across all these environments (Fig-
ure 3.3b). A similar absence of linear scaling between the end-point fluorescence and the
fibril concentration has been observed for other protein systems [145, 146], indicating that
ThT in situ assays are in general only semi-quantitative. As ThT molecules are known to
specifically bind to β-sheet structures [142], I hypothesise that the different trend between the
fluorescence intensity and the protein endpoint concentration for in situ and ex situ assays
originates from the ThT molecules binding to the formed protein aggregates already over
the course of the in situ assays, thereby resulting in a different morphology and, hence, ThT
sensitivity of the formed fibrils.
To examine the effect of the aggregation environment on the end-point fluorescence intensity,
I followed the aggregation of a pre-set concentration of insulin (0.5 mg mL−1) in aggregation
buffers of varying ionic strengths (20 mM to 300 mM NaCl) with (in situ) and without
(ex situ) the inclusion of ThT in aggregation medium. For the in situ assays the end-point
fluorescence was recorded directly in the aggregation environment, whereas the ex situ as-
says were monitored by withdrawing samples and diluting these into a set measurements
solution. Specifically, a 1:10 dilution into a 500 mM NaCl (pH 2) was chosen for the salt
that was present in the original aggregation solution not to affect the recorded fluorescence
values. I observed that in the in situ assays the presence of salt had a marked effect on
the observed fluorescent signal (Figure 3.3c, red circles), making a connection between the
observed fluorescence and the concentration of aggregated protein challenging to establish.
By contrast, in the ex situ assay, the recorded fluorescence intensities were independent of
the salt concentration in the aggregation medium (blue circles), since the measurement was
always taken under set conditions. These data illustrate that ex situ assays open up the
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possibility to compare the extent of aggregation under different reaction conditions.
3.3.2 Automated ex situ assays in 2D microfluidic devices
The data in Figure 3.3 highlight the robustness of ex situ assays under varying solution
conditions compared to in situ strategies. However, the use of such ex situ analysis methods
in a conventional laboratory has been limited because the measurement process is slow, labour
intensive and requires large volumes of the aggregating protein mixture in order to allow for
a number of aliquots with macroscopic volumes to be extracted. Furthermore, extracting
aliquots perturb the aggregating sample, making it virtually impossible to reliably analyse
aggregation processes if quiescent conditions are required.
To overcome these limitations of conventional ex situ measurements, I devised and fabricated
microfluidic devices that enable ex situ measurements to be performed in an automated and
a high-throughput manner (Section 3.2). Specifically, pre-seeded insulin and ThT (30 µM)
solutions were injected into the device at flow rates of 50 µL h−1 and 200 µL h−1, respectively,
and the ThT fluorescence was monitored in the “mixing and labelling” area (Figure 3.2).
Under these conditions, for the ThT molecules to mix with the aggregating protein sample,
the former have to diffuse by
xdiff =
1
2 · wprotein =
1
2 · wtotal ·
Qprotein
Qtotal





= 40 µm, (3.3)
where the factor 12 arises from symmetry of the device, wtotal and wprotein are the total width
of the microfluidic channel and that of the protein beam, respectively, and Qtotal and Qprotein
are the respective flow rates.






( (40 · 10−6)2 m2
2 · 8 · 10−10 m2 s−1
)
∼ 1 s (3.4)
Additionally, in a rectangular channel the centreline velocity of the fluid can be approximated
as





400 · 10−3 mm · 100 · 10−3 mm = 1.7 mm s
−1 (3.5)
In my designed device, the measurement was taken around 14 mm downstream of the point
where the fluids first mixed, corresponding to a well-defined location where the mixing
































Fig. 3.4 (a) The fluorescence intensity at each time point was calculated as the difference
between the fibril-bound form of the ThT at the centre of the channel (inset, blue
rectangle) and its unbound form at the edges of the channel (the average of the two
brown rectangles). Both values were averaged across rectangular shapes to eliminate
variations from potential non-uniform illumination of the imaging area. (b) Seeded
ex situ aggregation assays at 0.03 mg mL−1 (blue triangles) and 0.05 mg mL−1 insulin
(red circles) using the microfluidic device in Fig. 3.2. The data agree with the curves
obtained through manual aliquoting (yellow circles and squares).
channel curved (Figure 3.4) and by which the ThT molecules and the fibrils had mixed fully
(Figure 3.4, inset).
Figure 3.4b shows the seeded ex situ aggregation curves obtained at protein concentrations
of 0.03 mg mL−1 (blue triangles) and 0.05 mg mL−1 (red circles). The curves were obtained
by recording the fluorescence intensity in the measurement area (Figure 3.4a) at 60 second
time intervals. At each time point, the fluorescent reading was estimated as the difference
between the intensity of the aggregate-bound ThT in the centre of the microfluidic channel
and that of the unbound ThT at the edges of the channel. Both values were averaged
across rectangular shapes in order to eliminate any variations from potential non-uniform
illumination of the imaging area. From the acquired data I observed that the fluorescence
signal at long times when the aggregation process had reached completion was proportional
to the initial monomer concentrations, as expected for ex situ measurement (113 ± 6 AU
and 192 ± 11 AU for 0.03 mg mL−1 and 0.05 mg mL−1, respectively; average of n = 30
final values). The observed two-level fluctuations in the data are likely to have arisen from
pulsation of the flow.
3.3 Results 33
To validate these results, the obtained aggregation curves were compared to the data acquired
when the process was studied using conventional manual ex situ approaches. Specifically,
these experiments involved preparing a number of separate aggregation assays and detecting
the presence of fibrils at selected time points of interest using a new parallel assay every
time. The ThT was added to a final concentration of 30 µM and the fluorescence intensity
was recorded on a microplate reader right after the probe molecules had been introduced. I
found that the aggregation curves obtained on the microfluidic platform agreed well with the
manual assays (Figure 3.4b).
3.3.3 Automated ex situ assays in 3D microfluidic devices
The 2D device could be effectively used for following protein aggregation at low protein
concentrations. However, at higher concentrations, adhesion of protein fibrils to the PDMS
surface was observed. For instance, the bottom inset of Figure 3.5a shows the adhesion of
protein fibrils to the PDMS walls of the microfluidic device (green circles) at a concentration
of 0.2 mg mL−1 after 2 hours. In order to follow the aggregation process accurately at higher
concentrations, three-dimensional (3D) devices were built that allowed the sample aliquot
stream to be flanked by co-flowing labelling solution in all directions (Figure 3.5a, top inset),
thus preventing direct contact between protein and the walls of the microfluidic channel
where adhesion could otherwise occur. Such 3D devices were fabricated by bonding two
plasma activated PDMS polymers slabs to one another with one formed through a single layer
photolithography process and the other one through two subsequent photolithography steps
as described in detail in Materials and Methods (Section 2.1.3) . The channels through which
the buffered dye entered the device as well as the “mixing and labelling area” (Figure 3.2)
were fabricated onto both microfluidic chips so that they spanned across the height of the
device. The protein channel, however, was fabricated only onto the thinner layer of the ML
replica master, so that it would form the middle layer of the 3D device and would enter the
centre of the “mixing and labelling area” .
Using such 3D device a seeded aggregation curve at insulin concentration of 0.2 mg mL−1
was obtained (Figure 3.5b) to illustrate that the device opens up the possibility to study
aggregation at higher protein concentrations. As for the lower concentrations, the data was
seen to agree with manually performed ex situ where ThT molecules were introduced into
separate aliquots at various time points right before the measurement was taken. Moreover,
when normalising the three aggregation curves (0.03 mg mL−1 and 0.05 mg mL−1 in the
2D devices and 0.2 mg mL−1 in the 3D device) with respect to the intensity at long times
(the average of n = 30 final values) all the three curves were seen to a good approximation
collapse onto a master curve, as expected for first order kinetics observed under fully seeded

































Fig. 3.5 (a) At higher protein concentrations fibrils were observed to adhere to the
PDMS walls of the device - bottom inset: the measurement area after 2 hours at
protein concentration of 0.2 mg mL−1. To monitor the aggregation at higher protein
concentrations, I fabricated devices where the protein sample was flanked by co-flowing
buffer in all directions, which I achieved by bonding together a single layer chip including
the channel for the buffered dye and for the mixing and measurement area (green)
and a multilayer chip which included these same areas on its taller layer and only the
protein inlet channel (orange) on its thinner layer. Top inset: SEM image of the nozzle
of such 3D device. (b) Seeded aggregation curve of 0.2 mg mL−1 insulin using manual
































Fig. 3.6 When normalised with respect to the average of the n = 30 final values, the
three aggregation curves - 0.03 mg mL−1 (blue triangles) and 0.05 mg mL−1 (red
circles) in the 2D devices and 0.2 mg mL−1 (green squares) in the 3D device - were




The microfluidic devices demonstrated in Chapters 3.3.2 and 3.3.3 have a number of advan-
tages over conventional methods of following protein aggregation reaction. Most importantly,
spatial separation ensures that the aggregation reaction is decoupled from the measurement
process, hence eliminating interference between the probe and the aggregating protein of the
type that is encountered in in situ assays.
In addition to providing spatial separation between the two processes, the devices allow
the aggregation reaction and the measurement step to be performed in chemically different
environments. Thus, for example, a different buffer, such as one with higher ionic strength,
could be used to prepare the ThT solution in order to amplify the fluorescence signal [149]
but leaving the environment of the aggregation unaffected; the latter process could still take
place in a buffer with lower ionic strength. Furthermore, when a set measurement buffer is
used, comparison between aggregation reactions happening in different environments becomes
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possible as illustrated in Figure 3.3c (blue triangles).
The acquisition of ca 600 data points over a time period of 10 hours is more than an order of
magnitude improvement over manually performed ex situ measurements of protein aggregation
where the time resolution is usually of the order of tens of minutes as defined by the normal
aliquoting of a reaction cycle [150–153]. Moreover, as the process of transferring the protein
sample into the measurement system is continuous, fluid handling is no longer the limitation
of the achieved time resolution. Instead, it is the detection system that determines the fre-
quency of measurements. Therefore, the strategy outlined here opens the possibility to study
processes which exhibit fast kinetics and can be challenging to follow by manual aliquot taking.
A further key feature of these assays is that the small scale of microfluidic devices combined
with the lack of the requirement to physically separate macroscopic aliquots enables only
miniature volumes of protein solution to be used. More specifically, the 2D devices consumed
ca 500 µL of protein sample to obtain the full ex situ aggregation curve. As the high protein
flow rate is a necessary requirement to eliminate adhering of protein fibrils to the PDMS
walls, these simpler devices are best suited for experiments which are less sensitive towards
sample consumption. The 3D devices, however, are not restricted to the use of specific flow
rates as any interaction between the PDMS walls of the device and the protein is eliminated
due to three-dimensional flow. Specifically, in this work, ca 75 µL of protein sample (includes
a 25 µL dead volume connecting the syringe to the microfluidic device, this could be reduced
further) was sufficient to acquire the full ex situ aggregation curve (600 data points over
10 hours; 120 nL of sample per measurement point). The flow rate can be decreased further
until the precision of the syringe pumps is reached. Which of the two types of devices is more
appropriate for a particular experiment is a compromise between a multi-step fabrication
technique and the amount of protein sample consumed.
In addition to this, if following the aggregation process at high time resolution or continuously
is not of relevance, the syringe pump could be operated under a flow ramp with the protein
sample ejected only at the time when a measurement is to be taken or alternatively, control
valves could be integrated with the design [154, 155], decreasing the protein consumption
even further. This reduction could be particularly relevant for non-seeded aggregation assays
where high time resolution is more beneficial during some stages of the process than others.
This approach is applicable to both the 2D and the 3D devices.
Unlike conventional ex situ assays, this microfluidic setup does not rely on user interactions to
physically extract aliquots from the aggregation mixture, thus reducing the risk of perturbing
the sample and affecting the aggregation process. This is especially of import if fully quiescent
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aggregation conditions are required.
Last but not least, it is worth noting that the design strategy that this device uses can be
extended to other types of measurements where interference with probe molecules is not
desirable.
3.5 Conclusion and further developments
Conventional ex situ measurements yield high quality data but are labour intensive to perform,
can disturb the reaction mixture and allow reactions to be monitored only at limited numbers
of time points rather than continuously. To address these limitations, I devised, built and
demonstrated microfluidic devices that eliminate fluid aliquoting as the limiting factor on the
possible time resolution and instead allow continuous, real time and automated measurements
of protein aggregation assays, thereby offering a unique combination of monitoring the
aggregation process in a label free and in a high throughput manner. The use of these devices
could be extended to other measurement systems where avoiding interference between the
process and the measurement probes is desirable.

Chapter 4
New approaches for protein
separation under native conditions
This Chapter is based on the following publications and a patent application:
Saar KL and Zhang Y et al., Lab on a Chip, 18(1), 162-170, 2018
Saar KL et al., Analytical Chemistry, 90(15), 8998-9005, 2018
Saar KL and Müller T and Knowles TPJ. GB1720627.7. Filed (2017) and licensed (2018)
4.1 Motivation
Whereas the experiments described in Chapter 3 offer the possibility to monitor the protein
aggregation process in a label free environment and a precisely controlled automated high
throughput manner, in these devices performed the detection on the scale of the full assay,
only yielding information on the total amount of protein aggregates present. Aggregating
mixtures are known to be highly heterogeneous with differently sized aggregates exhibiting
a different level of toxicity. In the following two Chapters, I aim to develop separation
approaches that would be suitable for biomolecular separation and for yielding size resolved
data on the aggregation process, in addition to the time resolved information described
previously.
When separating molecules according to specific biophysical or biochemical properties, com-
mon platforms employ matrices to oppose chaotic molecular movement and keep identical
molecules in distinct bands. The integration of such matrices, however, severely limits
the speeds at which molecules can be fractionated with even the simplest one-dimensional
processes lasting for over an hour, a timescale that is poorly compatible with the dynamic
nature of many biological phenomena. Moreover, the involvement of matrices can affect the
relative strength of biomolecular interactions and result in preferential disassembly of selected
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complexes. Last but not least, their use prevents examining samples that exhibit significant
size variations, such as heterogeneous and self-assembled systems, as the larger molecules
present in such mixtures can obstruct the matrix pores.
A fundamentally different approach to controlling molecular movement and keeping molecules
of similar sizes together involves scaling down the compartment in which the process occurs.
As outlined in the Introduction of this thesis, in micron scale channels fluid flow is confined
to laminar layers with any molecular movement between the layers restricted to controllable
diffusion. Hence, if appropriately designed, micron scale separation systems can remove the
reliance on matrices integral to traditional separation platforms. Moreover, not only would
such micron scale separation systems decrease sample consumption and increase the recovery
rate in comparison to conventional matrix-based approaches, they would also allow molecules
to move through the separation area much faster, thereby enabling a second or a subminute
rather than an hour timescale operation. In this Chapter, I present a strategy for designing
such miniature separation systems and address two critical challenges associated with their
engineering, namely the effective integration of strong and stable electric fields as described
in publication [156], and increasing the resolution limit of the process based on the invention
described in patent application [157] and in publication [158].
4.2 Integration of electric fields with micron scale
channels
The traditional route to functionalising micron scale channels with electric fields involves the
incorporation of metal electrodes [159–163]. The generation of electrolysis products at the
electrode/liquid interface, however, imposes severe limitations on the stabilities of the systems
that exploit this strategy, especially when the separation is to be performed in conductive
media, such as biological aqueous buffers. Indeed, the prime concern in this context is the
formation of gaseous products on the electrode surface: the generated bubbles do not only
disturb the flow, leading to unstable separation, they also influence the strength of the field,
making quantitative characterisation challenging.
I first set out to estimate the required field strengths for performing biomolecular separation.
To achieve separation, molecules have to deflect to at least as far as the sample beam broadens
when moving down the electrophoresis chamber as a result of diffusion (Figure 4.1b):
xdef
2xdiffusion
= vdrift · tres√
2Dtres




· E · tres > 1, (4.1)
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Fig. 4.1 (a) Micron scale free flow electrophoresis (µ-FFE) involves the continuous
separation of molecules when they flow in a carrier medium and are subjected to a
perpendicularly applied electric field. This approach allows for continuous biomolecular
separation and its integration with relevant downstream processes. (b) While moving
down the electric field, the sample beam broadens due to the diffusive movement of
molecules. For effective separation the deflected distance, xdeflection, has to exceed the
diffused distance, xdiffusion.
where vdrift is the velocity at which the analyte of electrophoretic mobility, µel and diffusion
coefficient D, moves in electric field of strength E, and tres is the residence time of the analyte
molecule in the separation chamber.
Remarkably, the application of such fields in micron scale channels leads to the formation of
very noticeable amount of gaseous products. Indeed, for a representative protein molecule
with D = 10−10 m2 s−1 (Rh = 3 nm) and µel = 10−8 m2 s−1 V−1 (a protein with isoelectric
point in the range of 4-6 under physiological pH - around a third of the proteins in the human
proteome are predicted to have their isoelectric point values in that range [164, 165]), I can
estimate from equation 4.1 that separation on a second scale time scale - which is required for
molecules to move through micron scale channels - can be achieved at electric field strengths
above E > 20 V cm−1.
I can relate this electric field strength E and the amount of charge generated in a medium of
conductivity κ over a cross-sectional area A over time t through
q = I · t = (E · κ · A) · t = (E · κ · L · h) · t (4.2)
where I is the current flowing in the separation area and L and h are its length and the








(E · κ · L · h) · t
F , (4.3)
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gaseous products, where F is the Faraday constant, R is the ideal gas constant and T and p
are the temperature and pressure, respectively.
Finally, I can estimate the ratio of the volume of the generated gases and the volume of the
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From equation 4.4 I obtain that when an electric field of E = 20 V cm−1, as was esti-
mated to be the minimum strength required for the effective separation of representative
protein molecules as per equation 4.1), is applied, for instance, over t = 1 min time scale
in a w = 2 mm wide separation channel, the volume of gases generated is around equal
to the volume of the separation chamber itself even when only low conductivity buffers
(κ = 0.02 Ω−1m−1 corresponding to e.g. 10 mM phosphate buffer) are used. This result
indicates that in order to apply electric fields of the strength that enable separating protein
molecules over the time scales needed for most operations, effective strategies for either
continuously removing the generated gases or barriers for preventing them from entering the
separation area are required.
To address this issue, conventional macroscopic separation setups introduce ion-permeable
barriers between the electrodes and the separation chamber, preventing the gaseous products
from interfering with the separation process [166, 167]. Several approaches have been pre-
sented to similarly use physical structures for reducing the detrimental effects of electrolysis
products in micron scale separation platforms, such as physically separating the analysis cham-
ber from the electrodes by membranes [168–173] or by (partial) partitions [159, 167, 174, 175].
Alternatively, redox electron carriers have been used to suppress the formation and build-up
of gas bubbles [166]. Despite addressing the concerns related to the formation of gaseous
electrolysis products, these approaches introduce different limitations, such as significant
restriction on the applicable field strengths, intricate fabrication procedure, or both. More-
over, displacing gas bubbles does not overcome the issues that the presence of dissolved
electrolysis products creates, such as local changes in pH [167]. Finally, external electrodes
have been used to facilitate device fabrication alleviating the risk of gases being introduced
onto chip [176–178], but their placement at both inlets and outlets at the same time can still
result in electrolysis products and heat flowing through the device.
Due to these difficulties, current studies usually limit the applied fields to small values
where the rate of generating electrolysis products is low [166, 124, 81, 179, 180]. However,
efficient separation for more general purposes is possible only in the presence of strong electric
fields where the deflection of the analyte molecules in response to the field exceeds their
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diffusion over the same time [181, 182]. In this section I present a strategy for overcoming
the aforedescribed limitations and demonstrate a micron scale separation device that actively
transports away both gaseous and non-gaseous electrolysis products before they enter the sep-
aration chamber, thereby facilitating the application of strong and stable electric fields also in
aqueous biological buffers. Notably, the device can be fabricated in a straightforward manner
via a single layer lithography process and without involving alignment steps between fluidic
and metallic components as has conventionally been the requirement for micron scale separa-
tion systems. The device design strategy and the results are based on a published article [156].
4.2.1 Device design and operation
To facilitate the application of strong electric fields carrying high conductive currents, I
devised and implemented a strategy where the electric potential was applied outside the
chip and a highly conductive solution (3M KCl) used to simultaneously achieve two goals:
(i) actively transport all generated electrolysis products away before they come into contact
with the micron scale channels and the separation area and (ii) facilitate the propagation of
the electric field back into the device in the direction opposite to the flow (Figure 4.2a-b).
Specifically, the device contained three wide parallel channels connected by narrow perpen-
dicular channels (Figure 4.2a) and it was fabricated in poly(dimethylsiloxane) via standard
soft photolithography approaches with the structures sealed by quartz slides (Materials and
Methods, Section 2.1.2). The separation process occurred in the middle channel, which
included the analyte stream that was flanked by co-flowing carrier medium from both sides.
The two side channels contained the conductive electrolyte solution that transmitted the
electric field upstream to the electrophoresis area. The connecting channels between the
three main channels were designed to have a large hydrodynamic resistance to minimise mass
transfer of the electrolyte solution to the central electrophoresis area. They were further
designed to have meandering shapes such that the overall area of the device and hence the
variations in the height across its cross-section would be minimised. The flow out from the
separation channel was split towards two separate outlets - this prevented the positive and
negative liquid electrodes coming into close contact with one another and short-circuiting the
system.
The flow of the solutions to the device was controlled by syringe pumps (Materials and
Methods, Section 2.1.4) and set to 280 µL h−1 with the injection rate of the carrier medium
being 19 times higher than that of the protein, such that the latter would form a narrow
beam at the centre of the chamber. As expected, due to the laminar nature of the flow under
our chosen operating conditions, the analyte molecules remained confined in the centre and







































Fig. 4.2 Device design. (a) The electrophoresis chamber was connected to co-flowing
electrolyte solution (3M KCl) through narrow perpendicular channels that control the
mass transfer of the electrolyte to the electrophoresis chamber forming a thin sheet of
electrolyte at the edges of the chamber (insets (i), (ii); visualised via the addition of
trace amounts of bovine serum albumin). The areas that are filled with the electrolyte
during the device operation are annotated in yellow. Electric potential was applied
from metal clips at the outlets of the electrolyte channels from where it propagated to
the electrophoresis channel along the flowing electrolyte solution. (b) The co-flowing
electrolyte solution transported the electrolysis products away from the chip while
simultaneously propagating the field in a direction opposite to the flow back into the
device.
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broadened minimally due to diffusion (Figure 4.2a, insets i-ii). The flow of the electrolyte into
the two side channels was adjusted to 330 µL h−1 - these conditions allowed the generation
of a thin sheet of the electrolyte along the edges of the main channel as is visualised in
Figure 4.2a where the flow of the electrolyte was visualised by the addition of 1 mg mL−1
bovine serum albumin (BSA)).
To integrate electric fields with the devices, hollow metal dispensing tips were inserted to
the outlets of the electrolyte channels serving as external electrodes from which the electric
potentials were applied. The electrolyte effluent was collected in sections polyethene tubing
connected to the metal clips (Figure 4.2b). Gas bubbles generated as a result of the electrolysis
process nucleated only at the interface of the metal clips and the electrolyte solution and
they were carried away from the device with the electrolyte flow such that they could not
affect the electric or the flow field in the microfluidic device. The metal clips were bent at
90◦ angles to restrict the build-up of hydrostatic pressure at the electrolyte outlets. To ensure
a stable operation, additional channels acting as hydrodynamic “resistors” were included
at the electrolyte outlets - their omission was found to result in asymmetric flow profiles in
the separation chamber as small variations in the depth to which the two metal electrodes
were manually inserted affected the fraction of the electrolyte flow that entered the narrow
perpendicular channels instead of moving directly to the electrolyte outlet. Moreover, these
meandering channels were designed to have large enough hydrodynamic resistances, Rh, for
the pressure drop across these channels to exceed the hydrostatic pressure in the linear section
(h ∼ 10 mm) of the metal clips:
Rh · Qel,out ∼ 9 · 1013
kg
m4 s · 300
µL
h ∼ 840 Pa ≫ ρ · g · h = 100 Pa (4.5)
where Qel,out is the flow rate of the electrolyte out of the chip, ρ is the density of the
electrolyte solution and g is the gravitational acceleration. The hydrodynamic resistance




wh3(1 − 0.63 hw)
(4.6)
with η being the viscosity of the solution flowing in the channel and w, h and L its width,
height and length, respectively. The use of such a design strategy ensured that the fluid
flow rates in the different parts of the device were controlled merely by the external injec-
tion rates and that they remained stable over the course of the separation process and beyond.
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Fig. 4.3 (a) The movement of bovine serum albumin (BSA) in the separation chamber
was recorded between 0 V and 54 V with a step size of 3 V using deep-UV fluorescent
microscopy relying on the intrinsic fluorescence of proteins in this wavelength range.
The images were taken between the third and the fourth connecting channels counting
from upstream (Figure 4.2,ii). (b) The intensity profiles were extracted to quantify
the movement of the molecules in the electric field and confirm that there was no
bulk movement of fluid in response to the field. (c) The current flowing in the
device was recorded at each of the voltages - first, under the conditions where the
protein sample and co-flowing buffer flowed in the chamber (green circles, average of
n = 3 repeats) and then replacing these by highly conductive electrolyte (3M KCl)
solutions (blue triangles, average of n = 3 repeats). These data were used to estimate
the electrical resistances of the electrodes (250 kΩ) and the overall device (398 kΩ),
indicating around 40% voltage efficiency with around 5% uncertainty. (d) From
these measurements, the electrophoretic mobility of the BSA sample was estimated
to be µel = vdriftE = (−1.58 ± 0.17) · 10
−8 m2 V−1 s−1 and its solution charge to be -
7 elementary charge units.
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4.2.2 Performance of the high field electrophoresis device
To examine the presence of electric field in the device, I injected bovine serum albumin (BSA
dissolved to a concentration of 2 mg mL−1 in 10 mM phosphate buffer) molecules via the
sample inlet and tracked their movement in response to applied electric field. The movement
of the molecules was visualised through their intrinsic fluorescence using deep-UV fluores-
cence microscopy (excitation wavelength of λexcitation = 280 nm; as described in Materials and
Methods, Section 2.3.2) exploiting the intrinsic fluorescence of aromatic residues of proteins in
this wavelength range. A voltage ramp from 0 V to 54 V with a step size of 3 V was applied
using a 500 V bench power supply (Elektro-Automatik EA-PS 9500-06) and the profiles of
the protein samples were recorded towards the end of the electrophoresis area at the position
indicated in Figure 4.2a inset (ii) - at this distance the deflection was small enough to ensure
that even at the highest voltages the protein molecules did not interact with the electrolyte
that entered the electrophoresis area via the perpendicular connecting channels. The clear
deflection of the negatively charged protein molecules towards the positively charged electrode
indicated the presence of electric field (Figure 4.3a).
To monitor the mass transport of the electrolyte solution into the main separation channel,
I supplemented the former solution with a low concentration of BSA (1 mg mL−1) and
observed its spatial localisation by UV microscopy when applying electric potential. As
desired, the electrolyte formed a thin fluorescent layer at the sides of the electrophoresis
chamber and remained at a constant position when the electric field was applied and varied
(Figure 4.3b), indicating that there was no bulk movement of the electrolyte fluid into the
separation area due to effects such as electroosmosis. Instead, the interface was described
by diffusion of the BSA molecules. Crucially, the diffusion coefficient of BSA molecules
(6 · 10−11 m2 s−1) is around two orders of magnitude smaller than that of potassium and
chloride ions (∼ 2 · 10−9 m2 s−1 [184, 185]). Therefore, within the same residence time the
electrolyte ions diffuse about six times further. Specifically, the average residence time of the
fluids within the electrophoresis chamber up to the measurement point was estimated to be
tres =
w · h · L
Q =
1.8 mm · 25 µm · 3.8 mm
280 µL h−1 = 2.2 s (4.7)





2 · 2 · 10−9 m2 s−1 · 2.2 s ∼ 100 µm (4.8)
This distance is an approximation as in reality the residence time varies across the cross-
section of the device and is higher closer to the edges of the channel than at the centre.
Nevertheless, with the width of the electrophoresis area being 2 mm, only small sections
close to its sides were filled with the electrolyte and the electric field across the majority of
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the width of the electrophoretic chamber could be assumed to be uniform. This conclusion
was later further confirmed by a linear relationship between the applied electric field and the
deflection of the BSA molecules (Figure 4.3d).
4.2.3 Quantification of the electric field
Having demonstrated that the devised and implemented downstream electrode strategy
allows for the application of strong electric fields, I next demonstrate that the devices can be
used for quantitative characterisation of biomolecules, including for the determining of their
electrophoretic mobilities and effective charges in solution.
To obtain this insight, I set out to devise a strategy for relating the applied voltages to the
electric field strengths. For this purpose, first, simultaneously with recording the fluorescence
profiles (Figure 4.3b), I acquired a current vs. voltage curve and obtained an estimate for
the electrical resistance of the system (REL,device = 398 ± 18 kΩ; Figure 4.3c, green circles).
I further noted that the separation area can be short-circuited by filling it with a highly
conductive solution, such as 3M KCl. I used this procedure to estimate the electrical
resistance of the electrodes (REL,electrodes = 250 ± 11 kΩ; Figure 4.3c, blue triangles), yielding




= 1 − REL,electrodesREL,device
∼ 40% (4.9)
and an uncertainty of around 5%. The calibration step was performed for each device sepa-
rately due to the differences that can occur in fabrication or in placing the metal electrodes
to the electrolyte outlet orifices, or in the solution conductivities.
I further obtained a theoretical evaluation for the electrical efficiency of the device based on
the estimates of the electrical resistance of the individual channels, the dimensions of which
are outlined in Table 4.1. Specifically, the total electrical resistance of the device comprises
of the electrical resistance of the electrophoresis channel REL,chamber, the electrolyte channel
REL,electrolyte and the perpendicular connecting channels REL,connecting-channels that link the
electrolyte channel to the electrophoresis area (Figure 4.2a):
REL,device = 2 · (REL,electrolyte + REL,connecting-channels) + REL,chamber, (4.10)
whereas the resistance of the electrodes can be estimated from:
REL,electrodes = 2 · (REL,electrolyte + REL,connecting-channels) (4.11)
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Table 4.1 The estimates for the electrical resistances of the electrophoresis chamber













25 25 25 0.08
Length (µm) 3600 3200 1800∗ 1800∗
Width (µm) 80 20 5600 5600
Height (µm) 25 25 25 25
Resistance
(kΩ)
72 256 160 0.5
∗ As an approximation only this fraction of the electrophoresis chamber was used that
the electrolyte ions do not reach. The edge of the channel where the electrolyte ions
diffuse is significantly more conductive than the central area that they do not reach.








with Li, wi and hi being the length, width and height of channel i and κi the conductivity of
the solution flowing in that channel. I noted that the resistance of the electrolyte channel,
REL,electrolyte, can be approximated as that of the narrow section at the end of it due to its
much narrower width and hence larger cross-sectional area but similar length compared to
that of the rest of the channel (w = 1.2 mm for the wider section and w = 80 µm for the
narrower section). From the dimension of the channels and the relevant conductivity values
(Table 4.1), I estimate the resistance of the device to be (equation 4.10)
REL,device = 160 + 2 · (72 +
256
5 ) = 421 kΩ
and that of the electrodes to be (equation 4.11)
REL,electrodes = 2 · (72 +
256
5 ) = 261 kΩ,
both agreeing well with the experimentally obtained results (Figure 4.3c, equation 4.9).
50 New approaches for protein separation under native conditions
4.2.4 Estimation of electrophoretic mobilities and solution
charges
The electrophoretic mobility, µelph, of molecules can be estimated from their movement in a







where vdrift is the speed at which the analyte molecules move in the direction of the applied
field. Due to the high aspect ratio of the separation chamber (wh =
2000 µm
25 µm = 80), the fluid
velocity along the majority of its width was constant and hence, the residence time of the
BSA molecules in the section of the channel up to the measurement point could be estimated
tres = 2.2 s as per equation 4.7.
The drift velocity vdrift of the BSA molecules was estimated from the deflected distances,
xdeflection extracted from the micrographs in Figure 4.3b and was found to vary linearly with
applied electric field (Figure 4.3d). From these data, I estimated the electrophoretic mobility
of the BSA molecules to be:
µelph,BSA =
vdrift
E = (−1.58 ± 0.17) · 10
−8 m2 V−1 s−1
Moreover, using the Einstein electrical mobility equation
q = µelph · kTD (4.14)
and a literature value for the diffusion coefficient of BSA (DBSA = 6.3 · 10−11 m2 s−1 [16]),
I estimated the solution charge of the BSA molecules to be -7 elementray charge units.
This estimate is in agreement with values obtained by previously described approaches for
estimating solution charges [186, 187].
4.2.5 Separation and analysis of biological mixtures
Determining native charges of proteins in a mixture I have shown that the
device described in this Chapter presents a combined ability to apply high electric fields and
maintain an accurate flow profile through the device even when strong fields are applied. This
opens up the further possibility of determining the electrophoretic mobilities of individual
biomolecules when they are present in mixtures.
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I demonstrated this possibility by applying an electric field to a mixture of BSA (pI 5) and
human lysozyme (pI 9) in 10 mM sodium phosphate buffer pH 7.4. The two molecules fully
separated under the electric potential (Figure 4.4) and I estimated their mobilities to be
(2.0 ± 0.2) · 10−8 m2 V−1 s−1 for the lysozyme and (−1.7 ± 0.2) · 10−8 m2 V−1 s−1 for the
BSA molecules (Figure 4.4b).
Detecting protein interaction native charges of proteins in a mixture. Due
to its liquid-phase operation, the described platform can be used for detecting interactions
between proteins and for further separating proteins and protein complexes from one another
directly in the native environment. To show the power of this approach, I examined the
mixture of an aggregate forming protein Amyloid-β (Aβ) and a molecular chaperone Brichos.
Aβ is a polypeptide that is prone to self-association and fibril formation, its assembly is
believed to play a critical and potentially a casual role in the development of Alzheimer’s
disease [118]. The pathway of Aβ aggregation involves a transient heterogeneous mixture
including oligomeric species of a range of different association numbers and structural forms.
Molecular chaperones play a key role in aiding the folding process of newly synthesised pro-
teins into their native states and preventing proteins from aggregating. Brichos in particular
has been found to inhibit misfolding and aggregation of Aβ both in vitro and in vivo [119, 188].
To investigate whether Brichos molecules bind to aggregated forms of Aβ protein, I incubated
a mixture of aggregated Aβ (24 µM) and fluorescently labelled Brichos (0.45 µM) and exposed
it to electric field to examine the presence of a fibril-chaperone complex. The proteins were
prepared and labelled as described in Materials and Methods (Section 2.3.1). By compar-
ing the behaviour of the individual Brichos molecules and that of its mixture with Aβ, I
concluded the formation of a complex between Brichos and Aβ fibrils (Figure 4.5a-b) and
further fully separated the fibril-chaperone complex from the individual chaperone molecules.
The occurrence of this interaction is in agreement with an earlier observation of Brichos
molecules binding to Aβ fibrils - this interaction is believed to inhibit the potential secondary
nucleation events that could otherwise occur on the fibril surfaces [189]. Non-covalent and
reversible interactions between biomolecules, such as proteins are the basis of an extremely
wide range of biophysical and biochemical processes and due to their modulation by solution
conditions, these interactions are best studied under native conditions in aqueous environ-
ments. My developed device is ideally suited for probing interactions in biological mixtures
as not only is there no interference with a support medium in contrast to more commonly
used biophysical separation techniques, such as chromatography or protein gels, it also al-
lows probing these interactions at short timescales not accessible with conventional techniques.
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Fig. 4.4 Separation and analysis of a protein mixture. (a) UV fluorescent mi-
crographs and extracted fluorescence profiles (red rectangle) of the separation of
bovine serum albumin (BSA; 2.5 mg mL−1; pI 5) and human lysozyme (Lys;
4.0 mg mL−1; pI 9) at (i) 0 V cm−1, (ii) 30 V cm−1, (iii) 80 V cm−1.
(b) The profiles were used for the quantification of the electrophoretic mobilities
of the two proteins in the mixture - µelph, lys = (2.0 ± 0.2) × 10−8 m2 V−1 s−1 and
µelph, BSA = (−1.7 ± 0.2) × 10−8 m2 V−1 s−1 - calibrating the device as described in
Figure 4.3c.
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Fig. 4.5 Brichos molecules were labelled with a fluorescent dye (Alexa 488) and mixed
with Amyloid-β fibrils in order to test their binding to the fibrils. By comparing the
behaviour of (a) pure Brichos and (b) Brichos molecules mixed with the fibrils, I
concluded the formation of Brichos-Amyloid-β fibril complex and purified this complex
from the unbound Brichos molecules.
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4.3 Enhancing the resolution limit of free flow elec-
trophoresis
Despite its attractive features, micron scale separation platforms have remained limited in
their ability to work with heterogeneous samples. In addition to the lack of effective and
reproducible methods for the integration of electric fields with micron scale channels, an
additional challenge has been the limited number of components that current electrophoretic
devices can separate. In this Section, I first describe the underlying causes for this limitation
and then proceed with addressing its most critical contributions with the goal to yield a
strategy for advancing current resolution limits. The work is based on the patent application
described in reference [157] and publication described in reference [158].
From the data in Figure 4.3a-b, I observed that when the protein sample deflects in response
to the applied field, the beam broadens significantly, affecting the ability of the device to
effectively separate and analyse complex mixtures. The observed variance of the analyte
band, σ2total, can described as the sum of the variance contributed by several sources: the
finite bandwidth of the sample stream (σ2inj), diffusion (σ2D), hydrodynamic (σ2HD) and
electrodynamic (σ2DE) effects, electrohydrodynamic distortion (σ2EHD) and Joule heating
(σ2JH) [190]:
σ2total = σ2inj + σ2D + σ2HD + σ2ED + σ2EHD + σ2JH (4.15)
Effective approaches for supressing the latter three of these effects have been proposed and
demonstrated previously [182, 191, 192]. Specifically, in the experiments performed in this
Chapter (Section 4.2), I removed electrohydrodynamic broadening contributions by dissolving
the sample in the same buffer as the carrier medium [182, 193] and concluded the absence of
significant electrodynamic broadening effects from the stable position of the electrolyte with
varying electric field strength (Figure 4.3b). The absence of the electrodynamic broadening
contribution was further confirmed by the linear relationship between the drift velocity of the
molecules, vdrift, and the applied field, E, (Figure 4.3d), which would not be the observed in
the presence of notable electroosmotic flow involving bulk movement of the electrolyte solution
within the separation chamber. Indeed, the observed variance of the beam, extracted from
the data shown in Figure 4.3b, could be characterised well by the diffusive and hydrodynamic
broadening effects, with the two contributions approximated as described by Fonslow et
al. [181] (Figure 4.6):


















Fig. 4.6 The variance of the analyte beam at each of the applied voltages (blue circles)
based on the results in Figure 4.3. The broadening can be described by equation 4.16
(black line).
where σ2inj is the variance of the injected sample band, and σ2D and σ2HD describe the its
variance arising from the diffusive and hydrodynamic broadening effects, respectively.
However, strategies that would simultaneously eliminate the two factors that contribute
towards the broadening of the beams as a consequence of the fluid flow - diffusive and
hydrodynamic broadening - have been challenging to devise. Indeed, the former of these
effects appears due to the random diffusional movement of the analyte molecules and could
be in principle alleviated by increasing the fluid flow rate and thus the residence time of
the analyte molecules in the separation chamber. The latter contribution, however, arises
from the parabolic velocity profile along the height of the separation chamber with effectively
zero flow near the walls of the chamber due to non-slip boundary condition (Figure 4.7a,
inset) [181, 190] - this leads to a variation in the times that different analyte molecules spend
in the separation area and hence to their differential deflection. In contrast to the diffusive
broadening, this effect becomes particularly pronounced when high sample processivity is
required [158, 181] - increasing the flow rates of the sample and carrier fluid leads to an
elevated pressure drop between the inlet and the outlet of the device and hence, according
to the Hagen-Poiseuille law, to an increased velocity gradient and elevated variations in
the residence times of the analyte molecules. From equation 4.16, the relative width of the
sample beam in the electrophoresis chamber, σtotalw , can be described in terms of the relative
deflection of the analyte, C = xdeflectionw by which the analyte beam is deflected away from its

































From the latter equation, I conclude that the minimum broadening for a molecule with a
diffusion coefficient D at a specific relative deflection C occurs when the injection beam width
winj
w and the aspect ratio of the channel
h
w are both minimised and further when flow rate to
























Based on this estimate, the minimum possible analyte beam broadening at a specific relative

































Hence, for instance, for a relative deflection of C = 45% from the centre of the channel the
minimum possible beam width - defined as the full width of the beam at its half maximum
height - is over 8% of the total channel width for the case when the analyte is filling 5% of the
channel at the injection and channel aspect ratio of hw =
25 µm
2000 µm = 0.0125 as was used in this
work, indicating that the device could be used for separating up to 8 components depending
on how optimally their electrophoretic mobility values spread. Theoretically, for a relative




10000 µm , which could be achieved
by placing support pillars in the separation chamber, the beam width at a relative deflection
of C = 45% could be reduced from 12.5% to around 2.5%, while the less deflected analytes
would remain more confined to, for instance, 1.2% of the channel width at a C = 10% relative
deflection.
As such, the fast flow rates that would on the one hand suppress the diffusive broadening
extent, on the other hand lead to an elevated hydrodynamic broadening contribution. In






- - - - - - - - - -
- -
w0w
the velocity varies across


















Fig. 4.7 Broadening in free flow electrophoresis devices. (a) Pressure difference between
the inlet and the outlet of the separation chamber leads to a parabolic velocity profile
along the height of the chamber with nearly zero velocity in the vicinity of its walls
(inset). This leads to a variation in the times different analyte molecules spend in the
device and thus to the broadening of the analyte beam from its original width at no
deflection, w0, to a larger width, w, when the molecules are deflected, substantially
limiting the resolution of the separation process. (b) This effect can be alleviated by
selectively injecting the sample to the areas where velocity gradient and hence the
variations in the times that different molecules spend in the separation area are the
smallest, minimising the differences in their deflections.
this Section, I describe a strategy for overcoming this limitation and suppressing the two
contributions simultaneously. Specifically, I restrict the injection of the sample spatially only
into those areas of the separation chamber where the variations in the velocity distribution
are minimal (Figure 4.7b). I show how this strategy results in a five-fold increase in the
resolution limit compared to earlier described free flow electrophoresis devices and illustrate
that further enhancements in the resolution are possible when the sample is collected within
the central layers only. The device design strategy and the results are based on a published
article [158].
4.3.1 Simulating the broadening effect in 2D and 3D free flow
electrophoresis devices
To first test the theoretical enhancement in resolution that could be achieved using a controlled
sample injection strategy, I simulated the movement of individual particles - their diffusive
and advective transport in combination with their movement in a simultaneously applied
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electric field. To this effect, I modelled the behaviour of the particles in a 50 µm high,
1400 µm wide and 5000 µm long rectangular channel, as was later fabricated experimentally
(Section 4.3.3). The movement of the particles in the micron scale channels was simulated
using Langevin dynamics codes written in C++ [194]. The following equations were used to
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2D∆t · Random{−1, +1}, (4.22)
where the x-axis is in the direction of the length of the channel, y-axis in the direction
of its width, z-axis along is height and vx is the advective flux velocity in x-direction, ∆t
is the time internal for the simulations, D is the diffusion coefficient of the analyte, µ is
its electrophoretic mobility and E the strength of the electric field in the channel. The
simulations were carried out with reflective boundary conditions at the device walls using
a total of N = 2 · 106 molecules, which was found to be a large enough number to yield
smooth profiles and for understanding the movement trends within the channels. In order
to predict the profiles at a specific position along the channel the particle movement was
simulated to the point of interest along the length of the channel and the distributions
along the y-axis plotted by either averaging the particle distributions along the entirety
of the z-axis for full collection or along a section of interest only for spatially controlled
collection. Specifically, I modelled the movement of a representative protein molecule with
a diffusion coefficient of D = 7 · 10−11 m2 s−1 (hydrodynamic radius of Rh = 3.0 nm) and
electrophoretic mobility of µ = 2 · 10−8 m2 s−1 V−1. This is typical of a protein with
isoelectric point in the range of 4-6 under physiological pH - around a third of the proteins in
the human proteome are predicted to have their isoelectric point values in that range [164, 165].
I first modelled the movement of the particles in the electric field at a flow rate of 800 µL h−1
with the sample injected over the full height of the device. I observed there to be significant
variations in the distribution of the analyte molecules across the height of the chamber at the
device outlet (Figure 4.8a). Specifically, the molecules were more spread in the layers that
were further away from the centre (purple line - layers within 0-10% of the total height of the
device away from the wall; red line - layers within 20-30% of the total height away from the
wall) than in the central layers (green line - layers within 45-55% of the total height away
from the wall). All profiles were normalised by the total number of molecules in that layer.
These data indicate that a significant fraction of the protein molecules does not explore the
full height of the device but remain in the vicinity of the layer to which they were originally
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Fig. 4.8 Motivation for spatially controlled collection in free flow electrophoresis. (a) By
simulating the movement of the analyte molecules in the electrophoresis chamber, I
observed the analyte beam being substantially more spread in the layers that are
further away from the centre (purple line - layers within 0-10% of the total height
of the device away from the wall; red line - layers within 20-30% of the total height
away from the wall) than in the central layer (green line - layers within 45-55% of the
total height away from the wall). The blue line and orange lines correspond to the
profiles of the analyte molecules averaged across the full height of the device with and
without any electric field applied, respectively. The simulations were performed at
Péclet number of Pe = 22 with molecules injected over the full height of the devices.
All the shown profiles were normalised by the total number of particles in these layers.
(b) Based on this variation in the profiles, I propose that a further reduction in the
broadening of the analyte beam could be achieved by selectively collecting the sample
in the central area only.
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injected to. Indeed, under these conditions, the Péclet number, describing the ratio of the
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indicating that the diffusive time scale along the z-axis of the device is significantly longer
than the advective timescale along the x-axis. Whereas the layers the furthest away from
the centre of the device show the widest distribution in their deflections (Figure 4.8a, purple
line), I observed a tail in the distribution even in the central layers (green line) compared to
the profile with no field applied (blue line). This tail originated from the small fraction of
particles that diffused away from the central layers but also diffused back to these layers.
The data in Figure 4.8a suggest that an enhancement in the resolution could be achieved
by collecting the sample in the central layers only (Figure 4.8b). I explored this effect
further by modelling the behaviour of the particles in the electrophoresis chamber under
three different flow rates, 200, 800 and 2000 µL h−1, illustrate the sample behaviour un-
der different Péclet number conditions estimated to be Pe = 5.6, Pe = 22, Pe = 56 for
the three flow rates respectively. The distribution of the molecules across the width of
the chamber is shown in Figure 4.9a-c with no electric field applied (red line) and with
electric field applied while injecting the sample over the full height of the device (green
line), while injecting the sample into the layers within the central 10% of the height of the
device (blue line) and while further collecting the centrally injected sample only in the layers
within the central 10% of the device height (purple line). The applied voltage was kept
indirectly proportional to flow rate to ensure identical deflection under the different flow rates.
At low Péclet number, the differences in the profiles were observed to be small (Figure 4.9a).
Indeed, under these conditions the time scale for the diffusional movement along the height
of the device is comparable to that of the advective movement along the channel length,
meaning that a significant fraction of the centrally injected molecules can move away from the
position they were injected to and experience a longer residence time. Under these conditions
the broadening is predominantly arising from simple diffusive rather than hydrodynamic
broadening. In contrast, at high Péclet numbers (Figure 4.9b-c), the diffusive timescale is
significantly longer than the advective one and within the analysis time the molecules stay in
the central area where they were injected to such that the variation in their residence times
remains minimal. By combining the central injection and collection strategies, almost all the
hydrodynamic broadening effect can be suppressed (Figure 4.9b-c, purple line) with the high
flow rate also further suppressing diffusional broadening as can be seen when comparing the
peak intensities of the distribution profiles with and without applying the field (Figure 4.9c,
red and purple lines). The central injection and collection are of particular importance under
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Fig. 4.9 Comparison of the beam broadening effect with spatially controlled and
non-controlled sample injection and collection. The profiles were simulated at Péclet
numbers of (a) Pe = 5.6, (b) Pe = 22, and (c) Pe = 56, with no electric field applied
(red line) and with electric field applied while injecting the sample over the full height
of the separation chamber (green line), while injecting the sample to the layers within
the central 10% of the height of the device (blue line) and while also collecting the
sample only over the layers within the central 10% of the height of the device (purple
line). The applied voltage was varied inversely with the flow rate such that the analyte
deflection would remain constant between the different flow rates. The simulation
results indicated that the reduction in the broadening effect compared to conventional
free-flow electrophoretic setups is the most pronounced at the highest Péclet numbers
and when both the sample injection and collection are restricted to the central layers
only - under these conditions virtually all broadening can be eliminated.
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these high Péclet number conditions as the high flow rates and strongly pronounced parabolic
velocity profiles lead to an extremely wide width of the analyte beam when neither the injection
nor the collection is spatially controlled (Figure 4.9b-c, green line). Indeed, in conventional
free flow electrophoresis devices, the diffusive broadening effect decreases with increased flow
while the hydrodynamic broadening effect decreases with decreased flow and as such, there
is an optimum flow rate at which the overall broadening effect can be minimised [158, 195].
In contrast, for the spatially controlled injection and collection strategy modelled here both
the diffusive and the hydrodynamic broadening contributions decrease with increasing flow
rate. This generates the possibility to, in principle, remove all of the broadening effect
from these two sources rather than operate the devices under conditions which achieve a
compromise between the two effects but do not give the option to simultaneously prevent them.
4.3.2 Fabrication of high detection limit free flow electrophore-
sis devices with spatially controlled sample injection
Having established the attractiveness of spatially controlling the sample injection and collec-
tion, I next set out to fabricate such devices and validate the predictions experimentally.
Spatially controlled injection of samples has been achieved in macroscale devices (total
volumes order of millilitres) through the use narrow plastic capillary tubes penetrating into
the chamber and bent in the direction of flow [196]. Such capillary based sample injection
procedure would be challenging to achieve on micron scale, especially if more than one
component is to be accurately positioned as would be desired, for instance, when the analyte
is both injected and collected centrally to further increase the resolution of the separation
process [158]. To overcome this limitation and implement and implement spatial control
in micron scale setups in a scalable and reproducible manner, I instead used multilayer
soft-photolithography fabrication strategy involving the fabrication of polymer slabs that
include structures of varying heights. By bonding two such slabs to each other, it becomes
possible to form an orifice at the centre of the separation chamber wall through which analyte
molecules enter (Figure 4.7b) or exit the separation chamber.
With such lithographically produced devices the sheath flow regime can be established at the
moment when the sample enters the separation chamber and the electric field. Furthermore,
the carrier fluid could surround the sample at a range of geometries which is not the case
for an inserted capillary where the fluid always surrounds the sample instantaneously in a
sheath flow mode. Furthermore, whereas integrating central injection and collection simulta-
neously with their positions aligned with each another would be extremely challenging to
achieve with strategies that rely on the accurate placement of external components such as
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Fig. 4.10 (a) Fabrication of multilayer chips with integrated quartz windows for
enhanced fluorescence detection. 3D microfluidic devices were fabricated by bonding a
multilayer (ML; top row) and a singlelayer (SL; bottom row) chip to one another. A
quartz slide was incorporated into the SL chip before curing the PDMS and the PDMS
was then removed from the top of the quartz slide with a scalpel in order to introduce
a non-PDMS based observation hole for imaging. Fluidic ports were introduced only
to the ML chip. The two chips were plasma-bonded to one another and the hybrid 3D
chip was imaged via the observation hole fabricated into the PDMS so that the LED
light would not need to pass through PDMS for the excitation and the collection of
the emitted light. (b) The architecture of spatially controlled sample injection free
flow electrophoresis chip. The sample inlet and the connecting “bridges” between the
electrolyte channel and the separation chamber were fabricated onto the thin layer of
the ML PDMS chip mould only with the rest of the structures fabricated onto both
the thicker layer of the ML PDMS chip mould and the SL PDMS chip mould.
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capillaries, their simultaneous implementation involves no additional complications when the
devices are produced from lithographically fabricated polymer slabs. Last but not least, this
strategy ensures that the device is fabricated from a single material, which would allow their
production through scalable methods, such as injection moulding.
A major obstacle in producing the devices through such previously described multilayer
lithography approaches is the necessity to visualise the chip through the polymer in which
the microfluidic channels are produced. This requirement substantially reduces the sensitivity
of the setups as the majority of the polymers used for replicable production of micron
scale devices are either optically non-transparent or exhibit some degree of autofluorescence,
therefore generating noticeable background signals [197].
To circumvent this problem and effectively visualise the movement of the analyte molecules,
I devised a strategy for integrating observation windows with the regions of the chip that
were used for sample visualisation and analysis (Figure 4.10a). To achieve this objective, I
produced the two patterned polydimethylsiloxane (PDMS) slabs using a ML replica mould
for one of the slabs and a singlelayer SL mould for the other slab. I converted the former
mould to a PDMS chip using standard soft-photolithography approaches and the latter
by integrating a non-PDMS based observation window as illustrated in Figure 4.10a and
described in detail in the next paragraphs. The mould for the SL PDMS slab was fabricated
to a height of 50 µm and it included all the structures of the device with the exception of
the protein inlet and the ”bridges” connecting the electrolyte channels to the electrophoresis
chamber. The ML replica included structures of two distinct heights: the protein inlet as
well as the connecting “bridges” featured only on the shallow (5 µm) layer whereas the buffer
inlet, the electrophoresis chamber and the electrolyte channels were fabricated onto the tall
(50 µm) layers only identically to how they appeared on the SL mould.
To integrate non-PDMS based observation windows with the SL PDMS chip, small pieces of
quartz (ca. 5 mm × 5 mm) cut out from a 1 mm thick quartz slide (Alfa Aesar) were placed
on top of the SU-8 structures of the replica mould in the areas where the imaging was due
to take place (Figure 4.10a, bottom) before the structures were cast in PDMS. The quartz
pieces were carefully pressed against the SU-8 structures not to destroy the master mould
but to ensure that as little PDMS as possible remained between the quartz and the SU-8
structures. The PDMS was then cured by heating it at 65◦C for 2 hours - longer baking
times were found to cause strong adhesion of the quartz to the SU-8 structures. The PDMS
doped with quartz was then carefully peeled off from the SU-8 mould and the section of
PDMS above the quartz slide removed with a scalpel to generate a non-PDMS based area for
imaging where the excitation and emission takes place through the quartz (Figure 4.10a).
Inlets for fluidic connections were introduced to the ML PDMS chip using 0.75 mm inner




Fig. 4.11 The profile of the sample analyte beam (a) in conventional 3D device at
10 mg mL−1 and (b) in the hybrid 3D device at 3 mg mL−1. The inclusion of the
observation window was seen to substantially enhance the signal to noise ratio, opening
up the possibility of optical detection in structures that are embedded in polymer
matrices.
diameter reusable biopsy punch (World Precision Instruments), no ports were introduced to
the SL PDMS-quartz chip as it faced downwards during the imaging.
Finally, the SL PDMS-quartz hybrid chip and the ML PDMS chip were bonded to each other
to form the 3D injection orifice. To achieve an alignment accuracy of the order of micrometres
between the two chips, drops of water were sprayed onto the two plasma activated chips
before they were aligned under a stereomicroscope as described in Materials and Methods
(Section 2.1.3). Although in principle, the role of the two chips could be reversed with the
ML chip including the observation area and the SL chip including the inlets and outlets for
sample injection and removal, I decided to fabricate the quartz slide into the SL chip as
occasionally the SU-8 structures can come off from the silicon wafer together with the PDMS
and the production of SL chips is more straightforward than that of ML chips. A sketch of
the resulting device is shown in Figure 4.10b.
I compared the sensitivity of these 3D quartz-doped PDMS devices including dedicated
areas for detection to the sensitivity of 3D PDMS devices through conventional multilayer
soft-photolithography processes. I observed an order of magnitude enhancement in the signal
to noise ratio (Figure 4.11a-b). This enhanced sensitivity opens up the possibility to image
analyte molecules in structures embedded inside polymer matrices, such as the separation
device with a spatially controlled injection orifice under discussion here.
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4.3.3 Experimental performance of the free flow electrophore-
sis devices with spatially controlled sample injection
Finally, I explored the improvements in the resolution limit that can be achieved using such
spatially controlled sample injection strategy. To fabricate the devices, I used the fabrication
strategy described in Section 4.3.2 with strong electric fields integrated using the approach
developed and described in Section 4.2, where the electric potential was applied outside
and downstream of the microfluidic separation chamber and the field propagated back to
the separation area through the use of a co-flowing highly conductive electrolyte solution
(Figure 4.2a). While the narrow fluidic “bridges” between the electrolyte channels and the
separation chamber allowed the propagation of the electric field to the separation region
of the device, they simultaneously provided a high hydrodynamic resistance to prevent the
electrolyte from filling the full separation area and short-circuit the device but instead permit
its slow leakage into the separation chamber and the formation of a stable conductive sheet
on the edges of the chamber acting as an electrode. In this 3D device architecture, in addition
to the protein inlet channels, I also fabricated the connecting electrolyte bridges only in the
middle layer of the three-layered device (thinner layer of the ML chip mould) where their
height is low to ensure that with their lengths and widths fixed the “bridges” would have
their hydrodynamic resistance maximised but electric resistance minimised (Figure 4.10b).
To test the performance of the devices, injected bovine serum albumin (BSA) molecules and
carrier medium into the device via their respective inlets at 20 and 380 µL h−1 for the 2D
devices and at 4 and 800 µL h−1 for the 3D devices to yield similar profiles at 0 V cm−1 where
the beam width is determined by the original sample width and any diffusive broadening that
occurs. A voltage ramp from 0 V to 120 V was applied across the devices and the deflection
of the BSA molecules recorded by a home-built inverted UV-microscope (Figure 4.12a) for
both chips. The field strength was determined using the calibration strategy described earlier
where an independent estimate was obtained for the resistances of the electrodes by filling
the electrophoretic chamber with a highly conductive fluid [156].
The profiles at different field strengths for the 2D and 3D devices are shown in Figure 4.12b.
To quantify these results, the half-width of the analyte beam at its the full-height was used
as the parameter to describe the broadening effect. The broadening extent, describing the
difference in the half-width at a specific voltage and at 0 V, was found to be around five times
smaller for the devices with restricted injection (Figure 4.12c green triangles; 160 µm) than
for those with non-restricted injection (Figure 4.12c blue squares; 30 µm) at the maximum
deflection studied. I further note that it is possible to reduce the initial width of the analyte
beam by adjusting the relative flow rates of the sample solution and the carrier fluid. By doing
so, the width of the original beam can be reduced to very small values and in these cases, it is
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Fig. 4.12 (a) The profile of the analyte stream in the separation chamber with the
sample (bovine serum albumin) injected across the full height of the chamber (2D chip;
top row) and when its injection was restricted to the central area (3D chip; bottom row).
The walls of the electrophoresis chamber are defined by the fluorescent interface on the
sides which carries the conductive electrolyte solution. (b) The intensity profiles across
the red rectangular section shown in panel (a) for the 2D (left) and the 3D (right) chip
when increasing the field strength linearly from 0 V cm−1 (blue) to 140 V cm−1 (red).
(c) The broadening of the analyte stream was observed to be much less significant
when the injection was restricted to central areas only - specifically, at the largest
deflection studied the relative broadening was found to be around five-fold smaller
235µm − 75µm = 160µm vs 105µm − 75µm = 30µm).
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only the broadening extent which determines the effective resolution of the separation process.
This opens up the possibility to use micron scale separation devices for both, resolving a large
number of components from one another and resolving mixtures which include components
with very similar electrophoretic mobility values. The strategy of controlling sample injection
only to areas where the distributions in the velocity gradients are the smallest can be used to
similarly increase the achievable resolutions of separation approaches using strategies other
than electric field for the separation, such as magnetic, diffusive or thermal fields.
4.4 Conclusion
In this chapter, I addressed two challenges at the core of micron scale separation processes.
I first developed a strategy for integrating strong electric fields with micron scale that can
be applied in a stable and quantitative manner to achieve separation of individual proteins
as well as protein complexes. I then developed a strategy for substantially increasing the
resolution limits of micron scale separation approaches, enabling almost all of the broadening
effect encountered in conventional setups to be suppressed. The latter development is
expected to be of particularly great interest for the micron scale separation community due
to the substantial advancement that it facilitates through a relatively straightforward design
modification. Notably, the devices described in this Chapter have all their structures defined
lithographically, facilitating their reproducible production through readily scalable fabrication
strategies.
Chapter 5
An integrated protein separation
and analysis system
This Chapter is based on the following publication:
Saar KL et al., “Rapid two-dimensional characterisation of proteins in solution”, accepted.
5.1 Motivation
As described in the Introduction, microfluidic platforms are attractive for the analysis of bio-
logical samples because of their very low sample consumption and high recovery rate [94–98].
Notably, microfluidic platforms can provide unsurpassed analysis speeds both on the level of
individual unit operations as well as on the level of a combined workflow as several functional
units can be integrated directly without the requirement for transferring the sample between
the units or for integrating connector elements or tubes - such transfer processes do not only
extend the process but also introduce dispersion, thereby affecting the performance of the
system.
A crucial step in any workflow that involves working with non-homogenous mixtures is the
separation of components of interest, either to reduce the complexity of the mixture before
it is directed to further processing or to purify it. As far as combined on-chip separation
and analysis is concerned, continuous separation techniques are considered a particularly
attractive route to performing the fractionation as they allow separating analytes in the
direction that is perpendicular to their flow, thereby separating them spatially. This is in
contrast to batch separation techniques, such as capillary electrophoresis where the analytes
move in the same direction as the applied field, allowing their separation in time rather
than space. Although such batch separation approaches have be integrated with further
processing [100, 198, 199], their discontinuous operation limits the range and the complexity
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of downstream steps that can be performed due to the limited time that each fraction spends
in the analysis area before the arrival of the next fraction.
Whereas an array of methods has been developed for detecting the separated analytes on
chip, including both optical and electrochemical strategies [200–206], these readings can be
transferred to concentrations only in the presence of prior knowledge about the detected com-
ponents. As such, the uses of these detection techniques have remained limited to applications
where the analytes in each specific fraction are known or where their identities are determined
subsequently with an offline technique. Integration of separation and direct on-chip analysis
into a platform that in addition to detection would also characterise the separated fractions
has been seldom achieved. For instance, the possibility to simultaneously determine the
isoelectric points and concentrations of separated molecules has been demonstrated [206].
However, this result was achieved through the inclusion of intrinsic calibration markers rather
than through the integration of an analytical step, not serving as a general strategy for
combined on-chip fractionation and analysis.
Indeed, with conventional on-chip separation approaches, analytical information on the
separated components is usually obtained by an offline analysis and identification strategy,
most notably mass spectrometry [207–209] or SDS-PAGE analysis [192]. However, such
off-line analysis approaches eliminate one of the most attractive advantages of microfluidic
technologies - its fast processing speed - and hence limits the applications of the platform to
systems which are either static or only slowly evolving. In this Chapter, I demonstrate a
microfluidic device that overcomes this limitation of current analysis approaches and combines
onto a single chip a separative and an analytical step. Specifically, I use the continuous
separation strategy described and developed in Chapter 4 and a previously described on-chip
sizing approach [36]. In addition to enhancing the resolution of the analytical sizing tech-
nique, the device enabled me to rapidly construct two-dimensional characteristic maps of the
biomolecular mixtures directly in solution.
5.2 Integrated on-chip separation and analysis
In order to integrate onto a single platform a preparative and an analytical step that can char-
acterise and potentially identify the separated fractions, I used a separation strategy where
the fractionation occurred continuously, which unlike batch separation approaches permit a
tight control over the time intervals at which new fractions interface the analysis area [210].
Of the different modes of electric field mediated continuous separation strategies [166, 182],
free flow zone separation stands out in particular, as it provides an option to direct specific
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Fig. 5.1 On-chip separation and analysis of mixtures in liquid phase. By adjusting
the effective voltage ∆Veff , molecules of a specific electrophoretic mobility, µ = µel,
and hence of a specific q
Rh
ratio can be directed to the analysis area with those of
smaller (µ < µel) and larger (µ > µel) mobility values directed to the waste collection
channels. As the applied voltage can be varied, only a single analysis unit is required
and the width of the separation chamber can be kept constrained, allowing the device
to retain a high voltage efficiency and a fast processing speed. In the analysis area, the
fractions are sized through microfluidic diffusional sizing (MDS) by monitoring their
spatiotemporal motion under laminar flow conditions.
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fractions to analysis by simply adjusting the applied field strength. This is in contrast to
operational modes where a fixed gradient, such as pH (free flow isoelectric focusing) or
buffer mobility (free flow isotachophoresis) is applied across the separation channel - with
these techniques, the separation can be performed continuously but in order to analyse the
separated fractions, a separate processing unit is required for each fraction. Moreover, a
continuous separation approach where the field strength can be varied - such as free flow
zone separation as employed in this work - does not require separating the components out
simultaneously. Instead, by adjusting the field strength, fractions can be directed to the
analysis sequentially (Figure 5.1). This enables keeping the width of the separation channel
constrained which facilitates both, narrower devices and hence faster processing speeds and
the integration of stronger fields without increasing the applied potential.
Specifically, to develop a microscale device where the preparative and the analytical step occur
on a single chip, I used the free flow zone electrophoresis approach described in Chapter 4 to
fractionate analytes. By varying the applied voltage, ∆V, this module directed fractions of a
defined electrophoretic mobility, µel, to the analysis unit (Figure 5.1) [211]. The analytical
sizing step for each of the fractions was performed by monitoring the tempo-spatial movement
of the molecules under flow which, due to the laminar nature of the flow, could be directly
linked to their diffusion coefficients [36]. This allows to a certain degree identifying the
fractions that come out from the separation module, similarly to SEC-MALS (size exclusion
chromatography with multi-angle light scattering).
In addition to enhancing the resolution of the sizing technique, owing to the quantitative
nature of the electrophoresis unit, this device further enabled me to construct two-dimensional
characteristic maps of the native charges and the hydrodynamic radii of the analytes - much
like what could be obtained with two-dimensional electrophoresis gels. However, as the
electrophoretic separation step was performed in aqueous environment the devices ensured
that firstly, the two-dimensional map was obtained in the order of a few minutes which is
orders of magnitude faster time-scale than what could be reached with conventional and
non-aqueous phase based techniques, opening up the possibility to study not only static
but also dynamic systems. Secondly, the mixture was analysed in an environment where
the molecules were not affected by the presence of the support medium, which unlike gel
based methods permits the study of weak and non-covalent interactions that are affected
by the support medium. As such, this device opens up the possibility of multidimensional
characterisation of biological mixtures directly in solution and at time-scales that unlike




The device involved a native phase quantitative electrophoresis unit connected in series with
a microfluidic diffusional sizing (MDS) unit (Figure 5.2) [36]. This combined platform directs
a component of a specific electrophoretic mobility, µel, to on-chip downstream analysis as
a function of the applied electric field strength. The device was designed such that with
no field applied across the separation unit, none of the sample molecules flowed into the
analysis area. This objective was achieved by designing the three channels downstream of the
electrophoresis unit (“low mobility waste”, “analysis”, and “high mobility waste”) to have
different hydraulic resistances with ca. 63% of the flow directed towards the “low mobility
waste” channel, around 5% to the analysis area and the rest to the “high mobility waste”
channel.
In order to facilitate device operation in a stable manner and as a result allow quantitative
characterisation of the samples, I set out to minimise the number of individual units that
drove the flow in the device. For this purpose, the outlets from individual channels were
combined such that a single syringe could be used to apply a negative pressure at its outlet
(Figure 5.2) - this ensured that the flow in the individual channels was defined by the hydraulic
resistances of the lithographically produced high-accuracy channels, in contrast to a system
where the flows would be controlled by a number of external syringe pumps which could lead
to relative fluctuations between the flows of the different fluids over time.
The outlets of the electrolyte solution, however, were kept separated from the combined
device outlet to (i) allow applying electric potential across the device without generating an
electrical short-circuit and (ii) enable efficient removal of any generated electrolysis products
without them accumulating and causing pressure fluctuations or cavitation at the joint outlet
where the negative pressure was applied. Specifically, as described in Chapter 4, the electric
potential was applied on metallic connectors outside the chip - this ensured that all gaseous
products were generated on the metal and fluid interface outside the chip and not inside
the microfluidic channels. The flowing liquid electrolyte solution further ensured that the
generated electrolysis products were flowed away from the chip while the applied field was
propagated back to the chip instantaneously.
The flow of the electrolyte to the electrophoresis chamber was controlled by narrow perpendic-
ular channels (“bridges”; Figure 5.2) connecting the electrolyte channels to the electrophoresis
area. These channels provided high hydrodynamic resistivity preventing the oppositely
charged electrode solutions from coming into contact with each another while still allowing













Fig. 5.2 Device design and operation. A free flow electrophoresis unit (green), allowing
rapid separation of analyte molecules in their native phase and yielding quantitative
information on the separation process, directed fractions of the sample (yellow) to
a downstream analysis process involving microfluidic diffusional sizing (MDS; pink).
The sample was characterised by monitoring a single imaging frame (top right inset)
to simultaneously extract the sizes and the charges of the separated fractions. The
device was operated by applying a negative pressure at its outlet with a Y-shaped
off-chip flow splitter keeping the solutions from the “low mobility waste” and “high
mobility waste” channels separated to avoid partial short circuiting of the device. The
electric potential was applied from the electrolyte solution outlets employing a flowing
electrolyte solution as described previously. The flow of the electrolyte solution, which
included a fluorescent tracer of 1 mg mL−1 BSA for its visualisation, was chosen such
that the electrolyte would reach its outlet rather than be withdrawn into the separation
chamber without reaching it (top left inset), yet it would leak into the chamber by a
controlled distance, leaving sufficient space for deflecting the sample beam (bottom
inset).
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some of the electrolyte to flow to the electrophoresis area and through this provide direct
fluidic and hence electrical connectivity between the electrophoresis chamber and the elec-
trolyte channels. To maximise the efficiency of the electric field, I required these channels to
have a high hydraulic resistance RHD per electrical resistance REL:
RHD
REL





where ρel is the resistivity of the electrolyte and R∗HD =
ηL
A2 is the hydraulic resistance of the
channel depending on the viscosity of the fluid in it, η, its length, L, and on its cross-sectional
area, A. The geometrical correction factor, α(γ), is defined as a function of the aspect ratio
of the channel γ = wh as α =
π3
8 γ
2 f(γ) with w and h being the width and the height of the







With the height of the channel being fixed by the requirement for collecting a sufficient
amount of signal for imaging (it was set to h = 50 µm), equation 5.2 is maximised when
γ f(γ) is maximised. Specifically, for a rectangular channel, the correction factor f(γ) has










Thus, from equations (5.2) and (5.3), I realised that the bridges achieve a maximal hydraulic
per electrical resistance value in the limit of γ → 0. Due to fabrication of lithographic
channels becoming challenging at aspect ratios greater than around 4-5, I fixed the width of
the connecting channels to w = 18 µm.
I noted that during the operation of the device, the small amount of electrolyte solution that
was designed to flow to the electrophoresis channel and generate a wall at the edges of the
chamber (Figure 5.2, bottom inset) ultimately reached the combined outlet, bringing the
two oppositely charged electrolyte solutions into contact with one another, thereby reducing
the potential across the electrophoresis chamber. In order to circumvent such partial short
circuiting, I used a Y-shaped flow splitter to prevent the oppositely charged electrolyte
streams coming into contact with each other at the device outlet but only further downstream
where they reached the splitter (Figure 5.2). Crucially, the tubing connecting the two streams
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was filled with distilled water (18 MΩ cm−1). Its length on each side of the Y-shaped splitter
was L = 40 cm and internal diameter dID = 0.86 mm. With the flow rates of the solutions
into the two sides being around 320 µL h−1 and 80 µL h−1 as estimated in Section 5.3.2, it
would therefore take around
t =
π · (dID2 )
2
Q (5.4)
t1 = 43 min and t2 = 170 min for the fluid to reach the flow splitter from the two sides. Even
when accounting for Taylor dispersion in the tubing, this time scale is significantly longer
than the imaging period (∼ 5 minutes) and as such the voltage efficiency of the device can
be assumed to remain unaffected throughout its operation.
5.3.2 Fluid flow in the device
The device was designed such that at the end of the electrophoresis chamber the fluids would
split in a 1:12:2 ratio (63%, 5%, 32%) ensuring that no sample molecules flowed to the analysis
area when no electric potential was applied across the separation chamber. Furthermore,
the sample flow to the electrophoresis unit was designed to be in around 1:25 ratio with
the carrier medium and in around 1:10 ratio in the diffusional sizing unit. The “bridges”
between the electrophoresis area and the electrolyte channels were designed such that the
device would retain as high voltage efficiency as possible while the flow of the electrolyte into
the separation area would be minimised, leaving as much area as possible available for the
separation process (equation 5.1).
The flow rates in each of the individual channels were estimated by solving a set of simultaneous
equations:
Qcm + Qs + 2 · Qd + 2 · Qel,in = Qout + 2 · Qel,out (5.5)
2 · Qd + Qlm + Qa + Qhm = Qout (5.6)
2 · Qd + Qa = Qsizing (5.7)
Rcm · Qcm = Rs · Qs (5.8)
Rbridge ·
(Qel,in − Qel,out)
N = Rel,out · Qel,out + Rcm · Qcm (5.9)
Rlm · Qlm = Rhm · Qh, (5.10)
Rlm · Qlm = Ra · Qa + Rsizing · Qsizing (5.11)
Rcm · Qcm + Ra · Qa =
1
2Rd · Qd (5.12)
where Qi and Ri correspond to the flow rate in channel i and to the hydraulic resistance
of that channel, respectively, as indicated in Figure 5.3a. Equations 5.5 - 5.7 describe the
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mass balances for the total device, for the analysis area downstream of the separation unit
and for the diffusional sizing unit, respectively; equations 5.8 - 5.9 equate the pressure drop
between points A and B; equations 5.10 - 5.11 the pressure drop between points B and D
and equation 5.12 the pressure drop between points A and C. With the total withdrawal
flow rate from the device outlet set to Qout = 500 µL h−1 and the electrolyte infusion rate
to Qel,in = 80 µL h−1), the corresponding flow rates in each of the channels estimated by
solving the system of equations 5.5 - 5.12 are summarised in Table 5.1.
The microfabrication process that I used for producing the devices (Section 2.1.1) can be
estimated to be accurate to within a few micrometres with uncertainties originating from
printing of the acetate film transparencies as well as the fabrication process itself due to
effects such as the crosslinking reaction proceeding further than the UV illuminated area
and some of the cross-linked photoresist being edged away during the development step
(Figure 2.1b,c). As such, the dominant sources of errors in the calculations (equations
5.5 - 5.12) were the uncertainties in the width of the electrolyte bridges and in the width
of the channel that transferred the sample to analysis (Table 5.1). I assumed there to be a
2 µm error in the widths of these two channels. Using these estimates, I calculated the flow
rates in each of the channels for all the individual scenarios by similarly solving the system
of equations 5.5 - 5.12. The two critical flow rates that affect the quantitative analysis in
the following sections of this Chapter are the flow rate in the diffusional sizing channel (Sec-
tion 5.3.4) and in the electrophoresis chamber (Section 5.3.5). In particular, the calculations
predicted the combined flow of the carrier medium and the sample to vary between 184 and
204 µL h−1 in the electrophoresis chamber and between 142 and 145 µL h−1 in the diffu-
sional sizing channel to vary, indicating around 5% and 1.3% relative errors in these flow rates.
I observed that the flow rate of the electrolyte into the device had a notable effect on the device
performance. On the one hand, when the electrolyte infusion rate was low, the electrolyte
solution gets withdrawn into the main chamber without reaching its outlet (Figure 5.3b),
which can generate a reversed flow from the electrolyte outlet back to the electrolyte chan-
nel, ultimately resulting in some of the electrolysis products entering the chip. Indeed, at
electrolyte infusion rate of Qel,in = 30 µL h−1, by solving the system of equations 5.5 - 5.12,
I estimated the flow at the electrolyte outlet channel to be Qel,out = −10 µL h−1. On the
other hand, when the electrolyte flow into the system was high, the electrolyte solution
leaks far into the separation channel. Specifically, at the infusion rate of Qel,in = 200 µL h−1,
again by solving the system of equations, I estimated that the electrolyte leaks in from
all the bridges at a rate of Qbridge = 25 µL h−1 or at a total rate of around 250 µL h−1.
Under these conditions the combined flow of the carrier medium and the sample into the
electrophoresis chamber is Qcm + Qs = (201 + 8) µL h−1 = 209 µL h−1, indicating that over
half of the separation chamber is filled with the electrolyte (Figure 5.3c). At sufficiently high
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Table 5.1 The flow rates of the solutions in the channels of the device with the withdrawal
flow rate from the device outlet being Qout = 500 µL h−1 and the electrolyte infusion












Qcm 50 5.1∗ 603 188∗
Sample Qs 40 40.5 603 7.4
Carrier medium to
the sizing unit
Qd 50 8.6∗ 730 135
Low mobility waste Qlm 60 10.2 1561 172
High mobility waste Qhm 50 15.5 1561 80
To analysis Qa 30 2.5 128 13
Diffusional sizing
channel
Qsizing 100 25.0 1432 148
Electrolyte out Qel,out 60 4.5 101 25
Bridge Qbridge 18 6.9 704 7
∗ Two parallel channels of that length. The flow rate is given as the combined flow
























Fig. 5.3 Flow in the combined separation and analysis device. (a) The flow rates in
each of the channels were estimated by solving the system of simultaneous equations
5.5 - 5.12. (b) At low relative electrolyte flows (Qout = 500 µL h−1, Qel,in = 30 µL h−1)
the electrolyte solution was observed not to reach the electrolyte outlet (left) but to get
withdrawn into the separation chamber, not enabling the propagation of the electric
potential from the electrolyte outlet back to the device (right). (c) At high relative
electrolyte flows (Qout = 500 µL h−1, Qel,in = 200 µL h−1) the electrolyte reached its
outlet (left) but leaked too far into the separation chamber to permit directing the
sample molecules into the analysis area (right). The individual flows are summarised
in Table 5.1.
flows, however, the electrolyte reached its outlet (Figure 5.2, top inset) and generated thin
stable walls at the electrophoresis chamber walls (bottom inset) as desired. This infusion
rate was chosen for all further experiments.
5.3.3 On-chip microfluidic diffusional sizing (MDS)
The separation unit directed a fraction of the fluid flow to a microfluidic diffusional sizing
unit (MDS) which similarly to analytical light scattering setups connected to size exclusion
columns (SEC-MALS) allowed to a certain extent the identification of the fractions leaving
the separation module. The diffusional sizing process relied on surrounding the analyte
molecules with carrier medium and monitoring their diffusion into the medium in space
and in time as described earlier [36]. As the sizing measurement had to performed for all
applied voltages separately (Figure 5.4a-b), I adjusted the strategy from recording the profiles
at 12 different locations to recording them at 4 locations, and reduced the channel width
to ensure that only a single image would be sufficient for performing the sizing analysis
(Figure 5.2, red highlighted area). Moreover, to analyse the data and obtain the average
molecular size for each of the voltages, I replaced the Langevin dynamics based code used to
model the movement of individual particles in the microfluidic channels [194] with a numerical
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solver that enabled the predicted particle distributions to be generated significantly faster.
These predicted distributions were then, as before, compared to the experimental data to
extract the hydrodynamic radii of the particles in each of the fractions.
The positions of the four locations used for imaging (Figure 5.4b) were chosen such that
the first one would be as close as possible to the nozzle where the sample meets the carrier
medium - this placement allowed its usage as a reference point from which the movement of
the particles was propagated. The position of the furthest away point was chosen such that
for a representative protein with Rh = 3 nm (D = 7 · 10−11 m2 s−1), the molecules would
have diffused away from the centre of the channel but would have not yet become uniformly
distributed across it - such placement enabled maximising the amount of information that
could be extracted from the profiles. To enable accurate sizing of analyte molecules that are
orders of magnitudes larger or smaller in size, the length of the diffusional sizing channel
or the flow rate can be adjusted accordingly. Last but not least, in order to eliminate any
effect from the autofluorescence of the PDMS in the UV-wavelength, a background image
with no sample flowing in the device was also recorded and subtracted from the data before
the images were analysed.
5.3.4 Analysis of a binary protein mixture
I used the device to analyse a binary mixture of two sample proteins - bovine serum albumin
(BSA) and human lysozyme. In order to preserve the protein molecules in their native states
and enable a label-free analysis of the sample, the imaging was performed with a home-built
UV-wavelength based microscope that relied on recording the intrinsic fluorescence of the
sample by exciting their tryptophan and tyrosine residues (Materials and Methods). I first
confirmed the ability to separate the mixture into its components by applying a set of voltages
and recording the fluorescent profiles (Figure 5.4). I then operated the device by applying a
voltage ramp from −75 V to 75 V and instead of the separation area, recorded the profiles
downstream at the diffusional sizing area containing four sections of the channel as described
in Section 3.3. To precisely locate the imaging position the images were recorded at a position
where the corner of the first channel would be visible (Figure 5.2, top right inset; Figure 5.4b)
but only the part of the frame where the channels appeared straight was used for the sizing
analysis. The best fits to the individual profiles were used to extract the hydrodynamic radii
at each of the voltages (Figure 5.4c) and were found to be around 1.9 nm (at -20 V) and
3.6 nm (at 30 V). By noting that the obtained diffusion coefficient depends on the diffused






w · h · L , the
relative error in the diffusion coefficient and, hence, also in the hydrodynamic radii can be
estimated as:
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V = -25 V; Rh = 1.9 nm; V = +30 V; Rh = 3.6 nm;
(d)
0 V 75 V-75 V -20 V 30 V
Micrographs taken at the diffusional sizing unit (top right inset of Figure 5.2)
Micrographs taken at the end of the electropohresis chamber (bottom inset of Figure 5.2)
Fig. 5.4 Operation of the combined separation and analysis device. (a) The voltage
applied across the electrophoresis chamber (Figure 5.2, bottom inset) was adjusted
in linear steps to direct specific fractions to the analysis area. (b) The fractions were
then sized by imaging the diffusional sizing unit (Figure 5.2, top right inset) consisting
of four channels in which the extent of the diffusion of the analyte molecules into their
surrounding carrier buffer was monitored. (c) The latter images were used to find the
average size of the analyte molecules in each of the fractions by fitting the observed
fluorescent profiles for different hydrodynamic radii (Rh) and minimising the least
mean square error between the fit (red dotted line) and the data (blue continuous line).
































+ 0.0142 = 0.0312
(5.13)
where the error in measuring the diffused distance from the micrographs was assumed to
be minimal, the height (determined by a profilometer; Section 2.1.1), the width of the
channel were estimated to have an error of 2 µm and the uncertainty in the flow rate was
derived from the uncertainties in the channel dimensions (Section 5.3.2). The obtained values
are in agreement with the values obtained by using dynamic lights scattering (DLS). The
total fluorescent intensities across the imaging area and the recorded hydrodynamic radii
as a function of the applied electric potential across the separation channel are shown in
Figure 5.5a. Crucially, the extracted size was robust and was not affected by the intensity
and the concentration of the molecules in the analysis area.
The characterisation of mixtures which include molecules of similar properties is known to be
challenging because it requires deconvolution of an average signal, which is a difficult inverse
problem [36, 212]. As such, polydisperse mixtures are commonly analysed by first physically
separating the individual components within a mixture, for instance, by gel filtration or
another chromatographic method, and only then detecting and sizing the individual fraction-
ated species, for example, by absorbance or by light scattering. Indeed, when examining the
mixture of bovine serum albumin and lysozyme using DLS, the presence of averagely sized
molecules rather than that of the individual species was observed (Figure 5.5b, light blue
dashed line). Microfluidic diffusional sizing has been shown to improve on the deconvolution
capability of signals and through this enhance the resolution at which mixtures can be
characterised because it acquires data both in space and in time and thus increases the
accessible information content [36]. Its performance, however, has been shown to also become
limited when the analytes do not exhibit a few fold difference in their sizes [36], which in
biological mixtures occurs only for specifically chosen samples but not for mixtures that
include similarly sized proteins [16, 37, 38].
Mixtures of nanoscale molecules where the individual analytes are of similar size but exhibit
differences in their electrophoretic properties, can be rapidly characterised using the device
described here (Figure 5.5b, dark blue continuous line). Whereas a similar result could
have been obtained using an off-chip separation approach, the latter strategy would have
introduced the requirement for transferring the sample from one analytical tool to another or
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Fig. 5.5 Sizing of a mixture that could not be deconvoluted using standard sizing
techniques. (a) The sizes of the components in a binary mixture of lysozyme and
bovine serum albumin were found to be Rh = 1.9 nm and Rh = 3.6 nm. The obtained
sizes were robust and not affected by the fluorescence intensity and the concentration of
the molecules in the analysis area. (b) This binary mixture could not be characterised
using sizing techniques that do not involve pre-fractionation steps, such as dynamic
light scattering (DLS; light blue dotted line). Accurate size resolution became possible
using the combined microfluidic diffusional sizing and free flow fractionation platform
described here (dark blue continuous line).
only over a significantly longer timescale.
5.3.5 Two-dimensional characteristic maps of protein mixtures
In order to extract quantitative information from the separation step and specifically, to
relate the applied potentials to the electrophoretic mobilities of the species that were directed
to the analysis area at this voltage, I set out to estimate the voltage efficiency of the device.
Concurrently with the imaging, I recorded the current flowing in the device at each of the
voltages (Materials and Methods) and from these data, I estimated the resistance of the device
to be Rdevice = 644 kΩ. I then short-circuited the separation chamber by flowing a highly
conductive media in it and found the resistance of the electrodes to be Relectrodes = 521 kΩ,
indicating a 14% voltage efficiency.
The movement of a particle in electric field can be related to its electrophoretic mobility
though µel = vdriftE , where vdrift is the drift velocity of the analyte in the electrophoresis
chamber and E the strength of the electric field across the chamber. I noted that the electric
field applied here across the channel varied slightly as a function of the distance along the
electrophoresis chamber due to the additional amount of electrolyte that flowed in from the





















Fig. 5.6 Rapid two-dimensional characterisation of a mixture of bovine serum albumin
and human lysozyme. The quantitative nature of the electrophoretic separation unit
allowed the applied potential to be related to the electrophoretic mobility µel of each of
the fractions. These data were used in combination with the extracted hydrodynamic
radii (Rh) to estimate the effective charges (q) of the molecules in each of the fractions
and to construct a two-dimensional q vs Rh map of the mixture over a few minute
timescale by monitoring the device only at a single imaging frame.
side channels, slightly decreasing the effective separation between the two electrodes. Under








= δ · Q · w(w · h · L) · Veff
= δ · Qh · L · Veff
(5.14)
where Veff is the effective voltage across the separation chamber, δ is the observed deflection
and Q is the flow rate in the separation area (the sum of the carrier medium flow Qcm and
the sample flow Qs). As described, the device used in this work was designed such that the
molecules observed in the analysis area were those deflected away from their original position
by around 15% of the total width of the separation chamber or by around 300 µm. The
dominant contributors to the error in the electrophoretic mobility were the uncertainties in
the flow rate and in the voltage efficiency, which I estimated to be around 5% (Section 5.3.2)
and 9% (Section 4.2.3), respectively, leading to around 0.092 + 0.052 = 0.1032 or around 10%
error in the electrophoretic mobility value.
Using equation 5.14 to estimate the electrophoretic mobilities of each of the fractions and
by combining these data with the estimates that I had previously obtained for the diffusion
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coefficients for these fractions (Figure 5.4c-d), the electrophoretic mobilities of each of the
fractions could be directly converted to the native charges of the molecules in this fraction
using the Einstein relation µel = qkTD.
Based on these data, I constructed a two-dimensional characteristic map of the effective
charge (q) and hydrodynamic radius (Rh) of the mixture (Figure 5.6). The native charges
of the bovine serum albumin and the lysozyme molecules can be seen to be around −9 and
+6 elementary charge units, respectively, which are in agreement with the values estimated
using other techniques [186, 187, 213, 214]. The uncertainties in these obtained charge values












= 0.0312 + 0.1032 = 0.1082 (5.15)
Crucially, the full two-dimensional map was obtained from monitoring only a single imaging
frame, using only 4 µL sample. Depending on the desired resolution, such map can be con-
structed in a time period of around a few minutes, generating the basis for performing rapid
two-dimensional characterisation of mixtures directly in their native phase - this time scale is
orders of magnitude faster than what is required for running conventional two-dimensional
protein gels.
5.4 Conclusion
Current microscale on-chip separation approaches commonly rely on collecting the separated
fractions and sending these to offline processing rather than analysing them directly on
chip. This undermines one of the key advantages of microscale platforms - their fast analysis
speed - and may also introduce the requirement for additional fluid handling steps. I
demonstrated a microfluidic device that combines on-chip separation with direct on-chip
analysis - spatiotemporal diffusional sizing. By sizing a binary mixture of proteins that
cannot be characterised by existing solution sizing approaches, I showed that the device
extensively enhances the analytical power of the downstream analytical technique. Moreover,
due to the quantitative nature of the separation process, the device further allowed me to
construct a two-dimensional characteristic map of a heterogeneous mixture on a few minute
timescale, opening up the possibility of rapidly characterising mixtures directly in solution
and at time resolutions not accessible with current biophysical techniques.

Chapter 6
A high throughput platform for
detecting protein inside individual
cells
6.1 Motivation
Cells are fundamental units of life with each unit being unique. Conventional bulk scale
biophysical and biochemical analysis techniques allow accessing only population averaged
parameters, which give a fundamentally incomplete picture for describing what is happening
on the level of an individual cell, especially because functionally key cells are often present in
small numbers [83–85]. Although a range of experimental techniques has been developed to
describe the content and behaviour of individual cells, until recently, the majority of these
approaches have not permitted performing measurements at throughputs where they would
yield statistically significant system wide data [215].
Microdroplets platform [106–108] - involving the formation and manipulation of microscale
compartments - has opened up the possibility to increase extensively the throughput of bio-
chemical analysis and of single cell studies in particular. Indeed, analysing the transcriptomes
of individual cells has enabled innovative discoveries in areas ranging from developmental
biology to immunotherapy and cancer biology [86–91]. Such approaches have largely relied on
the use of DNA sequences that encode the cellular identities of molecules into oligonucleotide
codes, so that after the contents of individual cells have been barcoded inside compartmen-
talised microdroplets, the proceeding analysis could be performed on a bulk scale [215–217].
The applications of such DNA barcoding strategies to date have predominantly been centred
around analysing the transcriptomic content of cells. Here I aim to extend these approaches
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and develop a platform that can instead describe the heterogeneity in protein expression
between cells. Indeed, as described in the Introduction to this thesis, proteins are the chief
acting molecules of biology and involved in the execution of almost every biochemical process
occurring in cells. Whereas the synthesis of proteins is governed by messenger RNA (mRNA)
molecules that are the transcripts for protein production, previous work has shown that
mRNA and protein levels are correlated only in some cells due to factors, such as modulations
in translational efficiency and in protein half-lives [218] and that mRNA abundance can,
thus, not be used for the prediction of protein levels [219–222]. Moreover, tracking the
protein content opens up the possibility to further gain insight into the post-translational
modifications, including their signalling cascade activities as well as the into interactions
between proteins - these phenomena cannot be trivially predicted from measuring the mRNA
content only [221–223].
Profiling proteins in individual cells in a high throughput manner requires fast and sensitive
analytical tools. Currently used tools for analysing proteins inside individual cells are limited
in either their throughput, allowing only a small number of cells to be analysed in parallel,
or in the multiplexing extent, limiting the number of targets that can be simultaneously
monitored. Indeed, a widely popular cytometry based technique, fluorescence activated cell
sorting, involving the use of differently coloured dyes allows sensitive fluorescence based
detection to profile up to ten targets at a time [224, 225]. A more recently emerged cytometry
time-of-flight technique, which replaces the fluorescent tags on antibodies with heavy metals
and uses mass-spectrometer as the readout, can extend the multiplexing extent to a few
hundred targets [226, 227]. While both of these approaches can, in principle, at least to some
extent improve in their sensitivity and multiplexing capability, they are currently orders of
magnitude away from reaching the characterisation of full cellular proteome, estimated be
above 20,000 targets for human cells [228, 229].
6.2 High throughput single cell platform for analysing
intracellular proteins
To overcome these limitations of current approaches for detecting and analysing proteins
inside cells in a high throughput manner and develop an approach that would be virtually
unlimited in its multiplexing extent, I used DNA sequences as a means to barcode the
molecular identity of each protein. Crucially, using such a strategy, the devising of an effective
barcoding strategy was no longer the limiting factor to detecting a large number of proteins
simultaneously. For example, it can be estimated that only a ten bases long DNA sequence
provides over 410 ∼ 106 unique sequences, which is sufficient to barcode an antibody against
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every epitope in the human proteome. Moreover, the number of each specific type of protein
molecules inside individual cells is inherently small. Whereas no tools exist for amplifying
the protein content of cells, oligonucleotide content can be rapidly increased by conventional
molecular biology tools, such as polymerase chain reaction (PCR). Thus, such a strategy,
relying on the use of DNA barcodes for detecting and quantifying the presence of proteins,
ensures that even proteins that are present only at low concentrations can be detected. This
possibility is in contrast with using dyes or heavy metal molecules for barcoding, which
cannot be similarly amplified to achieve enhanced sensitivities.
The possibility to use DNA sequences for barcoding both the cellular and molecular identity
of protein molecules has been demonstrated for cellular surface markers [228]. However,
some of the very key proteins central to the onset of neurodegeneration in particular, are
located inside the cells and could thereby not be accessed with these previously described
approaches. The platform described in this Chapter provides a strategy that can facilitate
simultaneous profiling of intracellular targets as well as surface markers at an essentially
limitless multiplexing extent.
6.3 Results and Discussion
6.3.1 Preparation of oligonucleotide tagged affinity reagent
tagged library
As described in Section 6.2, tagging the affinity reagent library with oligonucleotides pro-
vides an effective strategy to a reach high degree of multiplexing and analyse a virtually
unlimited number of protein targets in parallel. To generate such oligonucleotide tagged
antibodies, I used copper-free click reaction based on strain promoted alkyne-azide cycload-
dition following the protocol by Click Chemistry Tools [230]. I would like to thank Marie
Synakewicz (Department of Biochemistry, University of Cambridge) together with whom the
first conjugation experiments were performed. In contrast to more commonly used copper
catalysed alkyne-azidecyclo addition reaction, which has been reported to be detrimental to
biomolecules, by causing their denaturation, for example [231], the strain induced version of
this reaction allows the reaction to be performed in a copper-free environment.
Central to this conjugation reaction was DBCO-PEG5-NHS ester, a bifunctional molecule,
which first reacts through its NHS-ester functional group with the lysine residues of the
antibodies, following which the DBCO group on the antibody reacts with the azide group on
the DNA (Figure 6.1a). Due to the reaction being non-specific, I would expect it to result in a





















Fig. 6.1 Preparing antibody-DNA conjugates. (a) The antibody is conjugated to DNA
by (I) activating it with DBCO using a bifunctional DBCO-PEG5-NHS ester molecule
that reacts with the lysine residues of the antibody and (ii) reacting the DBCO-activated
antibody with azide-modified DNA though copper free strain promoted alkyne-azide
cycloaddition click reaction. (b) Polyacrylamide electrophoresis gel confirmed successful
conjugation between the antibody and the DNA sequence. Each line included around
2 µg of protein. Lane 1 - protein ladder; lane 2 - unconjugated (control) antibody; lane 3
- DBCO activated antibody, lanes 4-5 - antibody-DNA conjugate. The reaction yields a
mixture including antibodies with a different number of DNA oligonucleotide sequences.
(c) The oligonucleotide sequence included a 7 nucleotide (nt) spacer sequence, 25 nt
priming region, 12 nt protein identification barcode and 24 nt hybridisation region.
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polydisperse product. A detailed protocol for the conjugation reaction is outlined in Materials
and Methods (Section 2.4.1). After performing the conjugation, its extent was examined
by analysing the reaction mixture on a polyacrylamide gel (Section 2.4.1). The reaction
was found to result in only minimal amounts of the conjugated product formed when it was
performed in the original storage buffer of the antibody (PBS, pH 7.36). This low reaction
yield is likely to be a result of a small protonation extent and, thus, low chemical reactivity
of the lysine groups at this pH. To increase their reactivity, I exchanged the buffer before
performing the conjugation reaction. Indeed, the reaction in 100 mM PBS at pH 8.0 was
found to result in successful conjugation with the product including a mixture of antibodies
with a different number of oligonucleotide sequences attached to it (Figure 6.1b; the molecular
weights of the antibody and the DNA were around 150 kDa and 22 kDa, respectively). The
polyacrylamide data show that the reaction mixture still included a significant fraction of
non-conjugated antibody. Although a further increase in the pH of the reaction environment
could potentially result in even higher reaction yields due to the increased protonation rate
of the lysine residues (pKa 9) at elevated pHs, such conditions may be unfavourable for the
antibody and were, thus, not investigated.
The DNA sequence that was attached to the antibody is shown in Table 6.1. The sequences
included regions serving different functional purposes (Figure 6.1c) - a spacer sequence (7 nt)
in the 5’ end, followed by a priming region (25 nt), protein identifier (12 nt) and a hybridisa-
tion region (24 nt) through which the DNA sequence becomes linked to the oligonucleotides
carrying cell identifiers as part of the barcoding step (Section 6.3.2).
Here, we proceeded by directly using the conjugated antibody for the experiments described
in the following sections. In the future, it may be beneficial to perform separate experiments
confirming the functionality of the antibody before its further use. Such examination could
be performed, for instance, through an SPR experiment or a conventional enzyme-linked
immunosorbent assay (ELISA).
6.3.2 Cell encapsulation and barcoding
Figure 6.2 describes the general strategy for barcoding the proteomic material of the cells.
Briefly, cells are co-encapsulated into individual droplets with the barcoded antibodies and
barcoding beads. This co-encapsulation process is performed using a microfluidic device
where two aqueous streams - one containing the cells and the other containing lysis buffer
together with the barcoding beads and the antibodies - are mixed on chip and individual
droplets pinched off by surfactant supplemented immiscible oil (Figure 6.2a). Each of the
barcoding hydrogels usually contains a large number of DNA sequences each carrying (i) a
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cell identification region (cell ID) that is identical between all the sequences within the same
hydrogel but differ between the hydrogels and (ii) so-called unique molecular identifier (UMI)
that is unique on every sequence, thereby allowing accounting for any potential bias intro-
duced in the amplification step. These sequences are linked to the hydrogel bead through a
(photo)cleavable linker and are cleaved off to initiate the barcoding process once the cells and
the beads have been co-encapsulated (Figure 6.2b). Such barcoding beads could be bought
or produced following the protocol described by Klein et al. [217]. For the proof-of-concept
experiments performed in this Chapter, instead of the barcoded hydrogel beads, I used DNA
sequences carrying placeholders for both the cell ID and the UMI (Table 6.1).
To illustrate the possibility of using such a strategy for detecting intracellular proteins inside
cells, I set out to detect the presence of protein kinase B (PKB) in SH-SY5Y cells using Human
AKT1 Matched Antibody Pair Kit (Materials and Methods, Section 2.4.1). The barcoding
process was performed by injecting the two aqueous streams - the cells and the lysis buffer
together with the barcoding beads and barcoded antibodies - into a microfluidic droplet maker
device at a flow rate of 150 µL h−1 and the FC-40 oil supplemented with 2% surfactant at a
flow rate of 800 µL h−1 (Figure 6.2a) as described in Materials and Methods (Section 6.3.2).
The lysis buffer included the barcoding DNA sequences at a concentration of 50 nM and
protein kinase B detector antibody at a concentration of 12.5 nM. These concentrations
ensured that there is sufficient cell identifier sequences available for every antibody molecule.
Moreover, with the size of the generated droplets being around d = 100µm, there are
Nmolecules =
1
2 · NA · c · V
= 12 · (6 · 10
23 molecules
mol ) · (12.5 · 10
−6 mol
m3 ) · [
π
6 (100 · 10
−6)3 m3]
= 4 · 106 molecules
(6.1)
of antibody in each droplet, where the factor 12 described the on-chip dilution. If proteins on
very high abundance are to be detected (with mammalian cells containing around 100 million
proteins in total, only a small number of proteins are present at concentrations higher than a
few million [232, 233]), higher concentration of antibody can be used.
Once a stable droplet formation had been established, around 150 µL of the emulsification
product was collected into a PCR tube with n = 3 tubes formed in total. Additionally, control
droplets were formed using an identical process with the aqueous inlet for the cell suspension
replaced with blank PBS with no cells (Figure 6.2). Inside the droplets, the cells lysed and
the DNA-tagged antibodies bound to the PKB molecules released from the cells and the DNA
sequences on these antibodies hybridised to the barcoding sequences (Figure 6.2b, Table 6.1).
This ensured that the cellular identify of each protein molecule (cell ID), the digital counting






(b) Barcoding of the genomic material
Cell lysis and relase of proteins
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5' - spacer - Fwd primer - protein ID - hybridisation sequence
hybridisation sequence - UMI - cell ID - Rev primer - 3'
(c)
Fig. 6.2 Schema for barcoding the proteomic material of cells. (a) Cells are co-
encapsulated with barcoding beads carrying barcoding sequences and with barcoded
antibodies library into individual microdroplets. (b) Inside the compartmentalised
environment the cells lyse and the proteins bind to their corresponding antibodies.
Simultaneously, barcoding oligonucleotide sequences hybridise to their complementary
regions on the 3’ ends of the antibody conjugated DNA (c) to bring together the
cell ID and the protein ID.
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Table 6.1 Summary of the DNA sequences used for the barcoding process.
Sequence
Antibody tag Azide - Spacer [7 nt] - Priming region [25 nt] - Protein ID place-
holder [12 nt] - Hybridisation region [24 nt]
5’ Azide - TTT TTT TGT CTC GTG GGC TCG GAG ATG
TGT ATA AGA GAC AGA CTT CAG CCT TAT CGT CGT
CAT CCT TGT AAT C 3’
Cell barcode spacer[7 nt] - Priming region [25 nt] - Cell ID placeholder [12 nt]
- UMI placeholder [8 nt] - Hybridisation region [24 nt]
5’ Acrydite - TTT TTT T AAG CAG TGG TAT CAA CGC
AGA GTA CAC GTT GCA TAG CNN NNN NNN GAT TAC
AAG GAT GAC GAC GAT AAG 3’
Fwd primer 5’ GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG 3’∗
Rev primer 5’ AAG CAG TGG TAT CAA CGC AGA GTA C 3’ ∗
sequence (UMI) and the type of each protein (protein ID) were incorporated into a single
entity (Figure 6.2c). The droplets were then de-emulsified using perfluorooctanol (PFO) as
described in Materials and Methods (Section 6.3.2) to form a continuous aqueous phase, of
which around 20 µL was carefully transferred into a clean PCR tube for further processing
and analysis as described in the following sections (purification and sequencing).
6.3.3 Purification of protein bound DNA-antibodies and in-
formation amplification
I noted that aqueous product produced after the emulsion was broken (Section 6.3.2), included
both, these DNA-conjugated capture antibody molecules that were bound a PKB molecule
and these that were not. To purify the product for it to include only those antibodies
that were bound to a PKB molecule, I used the detector antibody in the antibody pair
and conjugated it to a streptavidin magnetic bead as described in Materials and Methods
(Section 2.4.3). The magnetic bead conjugated detector antibody was mixed with the aqueous
product and only protein bound capture antibodies with their corresponding DNA sequences
pulled down (Figure 6.3a). The DNA sequences and antibodies were then released from the
beads (Figure 6.3b) by boiling the product in 0.1% sodium dodecyl sulphate (SDS; Materials
and Methods, Section 2.4.3) and 20 µL supernatant including only the DNA sequences of
interest transferred into a fresh PCR tube (Figure 6.3c). I estimate that this 20 µL of aqueous








Fig. 6.3 Purifying the DNA-antibody product and preparing the DNA library. (a) After
breaking the magnetic bead conjugated detector antibodies are used to the capture
antibodies that are bound to the protein molecules. (a) The unbound affinity reagents
are washed off, (c)the oligonucleotide sequences released from the beads and the 3’
ends of the sequences extended to encode the cellular and the molecular identity of
each protein molecule into one oligonucleotide sequence. (d) Finally, the product is






6 · (75 µm)3
= 20 000 nL0.5 nL = 38 000 cells (6.2)
To examine the presence of PKB, I amplified the product through polymerase chain re-
action as described in Materials and Methods (Section 2.4.4). Specifically, 6 µL of the
DNA library was collected and divided equally between three PCR tubes each involving
2 µL of the DNA product diluted into a 20 µL PCR mix. This corresponded to around
2 µL
20 µL · 38000 cells = 3, 200 cells in each PCR assay.
The samples were amplified on a qPCR for 35 cycles as described in Materials and Methods
(Section 2.4.4). Three independent replicates of the same experiment (cyan, red and blue
lines; the experiments involved cells that were cultured together but were run on separate
microfluidic devices (Figure 6.2) and through a separate purification process (Figure 6.3))
were performed and the amplification data indicated the presence of PKB molecules in all

























Fig. 6.4 Detecting the presence of protein kinase B in individual SH-SY5Y neuroblas-
toma cells. The presence of the protein in the cells was confirmed by amplifying the
DNA library by polymerase chain reaction and comparing the amplification process
to a sample with no cells. Each of the amplification curves (cyan, red, blue) involved
to around 3200 cells with the different colours corresponding to different experiments
and identical colours corresponding to parallel PCR assays of the same experiment.
The distribution of the protein in each of the cells could be obtained by sequencing the
DNA oligonucleotide pool.
the three samples (Figure 6.4). Double-stranded amplification products were also detected
in the control sample both when the experiments were performed in droplets (green) and
when they were performed in bulk (black). These products are likely to be a result of
non-specific amplification during the PCR reaction, non-ideal purification of the product with
the magnetic beads due to binding of the DNA sequences through non-specific interactions
or non-specific binding of the antibody as will be discussed in more detail in Section 6.4.
Crucially, the double-stranded product appeared at a smaller cycle number in all the cell
samples and from the fluorescent intensity was estimated to be around five times as abundant
as the non-specific product. Nevertheless, further optimisation of the protocol is required to
reduce the non-specific binding events and yield a library that would be even more dominated
by the product of interest.
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6.4 Conclusion and next steps
I have described and implemented an approach for detecting intracellular proteins inside
individual cells using a microfluidic DNA-based barcoding strategy. In addition to analysing
a large number of cells in parallel, this DNA-based barcoding strategy allows the analysis to
be performed on a virtually unlimited number of targets simultaneously, overcoming one of
the key disadvantages of current state-of-the-art single cell protein profiling approaches, such
as cytometry approaches that rely on fluorescence or mass spectrometry based readouts.
I demonstrated on the example of protein kinase B molecules in SHSY-5Y neuroblastoma
cells that the developed platform allowed successfully detecting the presence of intracellular
proteins in single cells. However, I observed that the strategy resulted in a higher than desired
amount of amplification products in the control samples that did not include any protein
molecules. This could be caused by at least two distinct factors. First, it is possible that
the magnetic bead based purification step (Figure 6.3) designed to remove unbound capture
antibody molecules did not result in their complete removal, thus, giving raise to a false
positive signal. This incomplete removal could have occurred, for instance, due to non-specific
binding of the DNA sequences to purification beads through electrostatic interactions. A
potential strategy for overcoming such non-specific binding could involve supplementing
the purification medium with a high concentration of an orthogonal DNA sequence (e.g.
poly-T), which would not get amplified in the proceeding PCR reaction but would decrease
the amount of non-specific binding of the sequences that are amplified by the PCR. Secondly,
non-specific primer annealing events could have occurred within the PCR reaction. Indeed, it
is not uncommon to observe non-specific amplification products after 25 PCR cycles. Their
occurrence could be reduced by further optimising the PCR protocol, most notably the
annealing temperature and the design of the primer sequence. It is a subject to further
experiments to validate the sources of these non-specific amplification products and to devise
strategies for suppressing their occurrence, as such an insight would enable preparing a better
optimised library for sequencing.
I noted that whereas the protocol here could be effectively used for detecting the presence of
protein molecules, in its current form, it does not allow cell specific quantification. Indeed,
during the step that involved a release of the DNA sequences from the magnetic beads
(Figure 6.3b-d), the reaction mixture was heated to 95◦C, which resulted in deannealing
of the two DNA sequences carrying the cell and the protein identifier sequences. In order
to overcome this limitation and allow preserving cell specific information, in the future,
the DNA extension reaction would have to be performed directly on the bead before the
biotin-streptavidin bond is cleaved.
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In conclusion, I have demonstrated an approach for detecting intracellular proteins inside
cells on the example of protein kinase B molecules inside SHSY-5Y neuroblastoma cells. This
approach sets the basis for a platform that enables a high throughput characterisation of
a large number of intracellular protein targets inside cells, far exceeding the multiplexing
extent of any previously described approach. Further optimisation of the protocol as outlined
in the previous paragraph is suggested to increase the sensitivity limit of the technique.
Chapter 7
High power density biological
photovoltaic devices (BPVs)
This Chapter is based on the following publication:
Saar KL et al., Nature Energy, 3(1), 75-81, 2018.
7.1 Motivation
Effective manipulation of cells has shown to set the basis for a diverse set of interesting
applications ranging from medicine and material science to energy generation [234–237]. In
the realm of energy generation, biological photovoltaics (BPVs; also known as biophotovoltaics
and biological solar cells) are emerging as an environmentally friendly and a low-cost approach
for harvesting solar energy and converting it into electrical current [238, 239]. Indeed, energy
demand driven by a rising global population must increasingly be satisfied from renewable
alternatives to fossil fuels, as the latter release extensive amounts of greenhouse gases with
potentially devastating consequences on our ecosystem. Solar power is considered to be a
particularly attractive source as on average the Earth receives around 10,000 times more
energy from the sun in a given time than is required by human consumption [240, 241].
Although a number of technologies exist to convert this extensively available sunlight into
electrical current [242, 243], factors such as scarcity of production materials, high cost per
delivered quantity of electricity, and lack of equally efficient storage technologies have limited
their adoption [243–247].
In the heart of the emerging technology of biological solar cells rely photosynthetic cells
that convert light into high-energy electron-hole pairs. The resultant excited electrons are
transferred through a number of intracellular electron carriers with a fraction eventually
exported across the cell membrane [248, 249] (Figure 7.1). These secreted electrons are















Fig. 7.1 In a BPV, high energy electrons (e−) are generated by the photosynthetic
cells in response to sunlight and some of these electrons are secreted to the external
environment through the exoelectrogenic activity of the cells. These electrons can
be brought into contact with the anode from where they flow to a lower potential
electrode, the cathode. Protons (H+) move to the cathodic chamber through a proton
permeable membrane where water is catalytically re-generated while the electrons
reach the cathode only via the external circuit.
directed to an electrode from where they are allowed to flow to a more positive potential
electrode, thus generating current. A proton permeable membrane separates the anodic
chamber from the cathodic one, ensuring that electrons travel between the two electrodes
only via the external load. Simultaneously, the protons released by the cells diffuse from
the anodic area to the cathodic one where water is re-formed. This process leads to the
generation of current without release of any chemical side products.
BPVs demonstrated to date rely either on suspending photosynthetic cells in solution or
immobilising them directly onto an anode [250]. In these designs, electron generation and
transfer to the electrical circuit occur in a single compartment, and the electrons reach the
anode and generate current as soon as they have been secreted (Figure 7.1). In this Chapter,
I propose, build and demonstrate two-chamber BPV devices, where the two key processes
involved in the operation of a BPV - generation of high energy electrons and their conversion
to current - are spatially decoupled from one another. With these devices, I improved on the
power densities of previously demonstrated biophotovoltaic systems around two and a half
fold using wild-type photosynthetic organisms and by fivefold using specifically generated
mutants [251].
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7.2 A two-chamber flow-BPV
I describe and demonstrate a two-chamber system where the two key process occurring in a
BPV - charging (reduction of the electron carrier molecules by exoelectrogenic electrons) and
power generation (electron transfer to the external electrical circuit) - are spatially decoupled
from one another (Figure 7.2). Such decoupling allows the geometrical configurations and
operating conditions for the two processes to be chosen independently, which in turn opens
up the possibility to optimise their performance simultaneously.
In particular, for the BPV system described and demonstrated here, I exploited miniaturised
geometries in the power generation unit. Operation at small length scales suppresses convec-
tive mixing [252], enabling the omission of the semipermeable membrane normally required
to separate the unit into anodic and cathodic compartments. In addition to decreasing the
internal resistance of the device, omitting the membrane reduces the cost of the system
and makes the operation easier as membranes have been reported to dry out, degrade, foul
and clog [253, 152, 254]. More generally, the use of small length scales has the potential to
decrease the resistive electrical losses of the system due to elevated surface-to-volume ratios,
enhanced mass transfer coefficients and small electrode separation [152, 254–256]. Such small
channels, however, are likely not to be the optimal geometrical configuration for the charging
unit, where instead a balance between the surface area and the depth of the vessel needs to be
found to facilitate the generation of the largest amount of charge carriers per illuminated area.
7.3 Results
7.3.1 Flow-BPV design
The power delivery unit of the BPV was fabricated in PDMS via soft photolithography
(Materials and Methods, Section 2.1.2) as a rectangular channel of a width of w = 250 µm,
length of L = 6000 µm and height of h = 25 µm with one inlet for the anodic and one for
the cathodic fluid (Figure 7.3). The anolyte and catholyte were injected into device through
their respective inlets with the former including photosynthetic cells suspended in their
growth medium (BG-11) together with electron carrier (EC) ions that facilitate the transfer
of the electrons released by the photosynthetic cells to the electrical circuit, and the latter
comprising of only the growth medium. Due to the similar viscosities of the two solutions,
the boundary between the two areas at the start of the chamber was determined by the
relative flow rates of the two fluids [257, 258].






























Fig. 7.2 In a flow-BPV, the charging process can be spatially decoupled from power
generation providing temporal flexibility over power generation and enabling indepen-
dent optimisation of the two processes. Inset (a): In the charging unit high energy
electrons (e−) are generated by the photosynthetic cells, some of which are released
to the external environment via the exoelectrogenic activity of the cells to reduce the
charge carriers (EC → EC−). Inset (b): In the power generation unit the reduced
charge carriers (EC−) are brought into contact an anode. In our devices, proton
permeable membranes were generated by controlled mass transport at small length
scales as described in detail in Section 7.3.1.
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Specifically, the fluids were injected into the device at flow rates of Qcatholyte = 16 µL h−1
and Qanolyte = 4 µL h−1, setting the interface a distance of 20% of the total width of the
device away from the anode (Figure 7.3, inset a). Such placement ensured that due to the
limited residence time of the fluids in the device, a significantly larger fraction of the electron
carrier ions would reach the anode than the cathode by molecular diffusion. Moreover,
the dimensions of the system were chosen such that protons, which have over an order of
magnitude higher diffusion coefficient than the electron carrier ions, could diffuse to the
cathode within the limited residence time of the fluids in the device while the electron carrier
molecules would remain in the vicinity of the anode. Indeed, under our chosen operating









0.025 · 0.25 · 6.5 · mm3 = 270 µm (7.1)
whereas the electron carrier (ferrocyanide was used for this purpose throughout the experi-









0.025 · 0.25 · 6.5 · mm3 = 74 µm, (7.2)
indicating that the majority of the protons reach the cathode whereas the majority of the
electron carrier ions do not.
To confirm that the flow profile under these conditions is indeed laminar, I estimated the
Reynolds number, Re, to be
Re = ρ u dH
µ
= 0.04 < 2000 (7.3)
where the fluid velocity, u, was estimated from




0.025 mm × 0.25 mm = 0.9 mm s
−1 (7.4)




4 × 0.025 mm × 0.250 mm
2 × (0.025 mm + 0.250 mm) = 45 µm (7.5)
Hence, under these operation conditions, an effective diffusion-controlled proton permeable
barrier between the cathodic and anodic areas is generated (Figure 7.4, insets b-c), permitting
the power harvesting unit to be fabricated without the inclusion of a membrane.








































Fig. 7.3 Schematic diagram (not to scale) of the power generation unit of the flow-BPV.
Cells and electron carrier (EC) in growth medium BG-11 were inserted into the anodic
area and the growth medium BG-11 into the cathodic one. Insets: (a) The flow rate
of the anodic fluid was set to be 20% of the total flow rate, so that the electron carrier
ions would remain in the vicinity of the anode. (b) The absence of inertial forces at
small length scales allowed generating a diffusion-controlled barrier (c) that can be




Throughout the experiments performed in this Chapter, Synechocystis sp. PCC6803 cells were
used as the biological catalyst, motivated by their previously demonstrated exoelectrogenic
activity [259, 260] and the availability of genetic tools for the generation of multiple mutations
in the genes encoding for electron transfer components [123]. K3[Fe(CN)6] was used as an
electron carrier and it was pre-mixed with the cells at a concentration of 30 mM at which
K3[Fe(CN)6] had previously been shown to be physiologically well tolerated by Synechocystis
sp. PCC6803 cells over extended time periods [260].
The performance of the power generation unit of the BPV was characterised while injecting a
mixture of the electron carrier and cyanobacterial cells in their growth medium (BG-11) from
the anodic inlet and the growth medium from the cathodic inlet (Figure 7.3). Before injection,
1 mL of the anodic solution was illuminated for 3 hours under red light at a constant output
of 30 µmol photons m−2 s−1 as described in Materials and Methods (Section 2.5.3) to reduce
the K3[Fe(CN)6] by the exoelectrogenic electrons released by the photosynthesising cells.
During this process the solution was spread over a circular area of a diameter of 1.0 cm.
The current-voltage (polarisation) curves for the devices were acquired by varying the ap-
plied voltage and recording the respective current at each voltage using a potentiometer as
described in Materials and Methods (Section 2.5.3). The resulting polarisation curves for
three independently fabricated devices are shown in Figure 7.4a. Unlike approaches that
change the resistor connected to the system and hence vary the voltage and the current
simultaneously, potentiometric measurements alter only one parameter at a time and have
become a commonly used method for BPV characterisation [261, 262].
From these measured polarisation curves, I deduced the internal resistance of the BPV to
be approximately 3 MΩ and its resistivity to be around 500 Ω m. Due to the varying area
between the anode (spanning the full length of the device) and the cathode (a point electrode)
the latter value is an approximation and was for the purpose of this estimate obtained by
using the average of the two areas. This resistivity value is substantially smaller than for our
previously built devices of larger scale - 19 kΩ m [260] and 69 kΩ m [239], both of which had
similarly used BG-11 as the carrier medium. This decrease is most likely to originate from the
reduced resistive losses at the smaller length scales and from the absence of a semipermeable
membrane in the design [152, 254–256]. Additionally, I did not observe a tendency for the
polarisation curves to show higher gradients, even at high currents. This finding indicates
that the performance of the device was not limited by diffusion or mass transfer [255, 261].
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Fig. 7.4 (a) The polarisation (left) and power (right) curves for the fabricated µ-BPV
devices (average of n = 3 repeats in three independently fabricated devices dev 1-3; error
bars correspond to standard deviations) with cells (circles; chlorophyll concentration
of cchl = 8 µM) and without cells (triangles). (b) The polarisation (left) and power
(right) curves on the first (blue circles) and second injection (black circles) and without
cells (light blue triangles) to verify that the cells can be recycled and the device reused.
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Small background currents were recorded when the device was operated with the anolyte
including only the growth medium and the electron carrier with no cyanobacterial cells (Fig-
ure 7.4a, triangles). Such background currents have been reported previously and attributed
to the ionic concentration of the medium and slow formation of electrolysis products at
the anode [263, 264]. This background current was similar between all the devices used
(Figure 7.4a, triangles).
The power curves for all the devices were constructed using the relationship
P = U · I (7.6)
and as in previous studies, the peak biotic power of each device was quoted as the difference
between the peak power of the device operated with cyanobacterial cells and the device
operated without the cells at the same current [250, 264]. From our data, the average peak
biotic power output for the µ-BPVs was estimated to be 13.9±0.9 nW (Figure 7.4a; average
of n = 3 repeats in the three independently fabricated devices) occurring at a current of 60 nA.
To analyse the possibility of operating the system in a recirculating mode (Figure 7.2), I
further collected the anolyte and catholyte solutions at the device outlets to test whether the
solutions and the device can be reused. After illuminating the anodic fluid for an additional
3 hours to recharge the electron carrier molecules, I re-injected the solutions to the device.
Crucially, the device performance was unaffected between the two rounds of recirculation
(Figure 7.4b), indicating the pressure drops inherent in the device operation did not damage
the device or the cells or affect their exoelectrogenic ability.
7.3.3 Optimal flow rate for the BPV performance
I expect the performance of the flow µ-BPV to depend critically on the flow rates of the
fluids into the anodic and the cathodic half-cells. On the one hand, at higher flow rates, not
all the charged electron carriers can diffuse to the anode within their residence time in the
device. On the other hand, at low flow rates, the reduced electron carrier ions can cross the
channel and lead to short-circuiting in the device. Indeed, such behaviour has been reported
for microbial fuel cells as the fuel cross-over concept [265, 266] where the termination of flow
has been observed to cease power outputs entirely [267].
The effect of the flow rate of the BPV performance was investigated by keeping the ratio of
the catholyte and anolyte flow rates fixed (QcathodicQanodic = 4) and recording the power curves at a
range of total flow rates. The peak biotic power outputs were then normalised by the number
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of charge carriers that entered the device in a given time. This normalised power output was
observed to decrease with the flow rate (Figure 7.5a, blue circles; average of n = 3 repeats).
This decrease can be accounted to less efficient conversion of the charged electron carrier ions
to current due to not all the charged carriers coming into contact with the anode at these
high flow rates. The disappearance of this trend at small flow rates, O(10 µL h−1) is likely
due to the effect of a more significant cross-over of the charged carrier, complete reduction of
the electron carrier or both.
I further simulated [194] the movement of the electron carrier ions in the channel to estimate
the fraction of ions that can diffuse to the two electrodes as a function of flow rate. The
experimental data for the normalised power was observed to follow a similar trend to the
simulations but the experimentally recorded power output was observed to decline faster than
the fraction of electron carriers that reach the anode according to the simulations (Figure 7.5a;
black line). Potentially other factors not accounted for in this simple model start to limit the
performance of the device, such as the availability of protons on the cathode or mass transfer
limitations at the surface of the anode.
One disadvantage of a flow-based system in comparison to those that rely on biofilm growth
on the anode is the viscous losses experienced by the fluids. For recirculation the fluids have
to be pumped back to higher pressures before they re-enter the device (Figure 7.2). The
energy dissipation in this process can be estimated to be:
Pfriction= [∆P × A] × u
= Rh × Qtotal × (w × h) ×
Qtotal
w × h
= Rh × Qtotal2
(7.7)
where ∆P is the pressure drop across the channel, A, w and h are its cross-sectional area,
width and height, respectively, and u and Q the velocity and the flow rate of the fluid. The hy-
drodynamic resistance of the channel, Rh, was estimated as described by Mortensen et al. [183].
Specifically, at a flow rate Qtotal = 20 µL h−1 the pressure drop can be estimated to be
∆P = 110 Pa and the associated frictional loss, Pfriction ≈ 0.5 nW, which is a small fraction
of the power generated by the device at this flow rate (14 nW; Figure 7.4a). The resulting
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Fig. 7.5 (a) The biotic power outputs normalised by flow rate (blue circles, average
of n = 3 repeats; Qcathodic
Qanodic
= 4 for all) decreased with flow rate. One of the factors
contributing towards this decrease is the reduced amount of electron carrier ions
reaching the anode (solid line). (b) The generated biotic power, power loss due to
friction and the net power output at different flow rates. Qtotal = 20 µL h−1 was chosen
for further experiments due to the net power output being at its highest at this flow
rate.
Similar estimates for the dissipated energy were obtained when the pressure drop, ∆P, was
instead approximated using the Darcy-Weisbach equation:
∆P = L · fDdH
· ρ · u
2
2 (7.8)
where L is the length of the channel and ρ the density of the fluid in it. The hydraulic





I further note that the actual required power input could be up to 50% higher due to non-ideal
operation of pumps (typical efficiencies range from 65% to 90%). This is nevertheless a small
fraction of the total generated power for all the experiments performed in this section and
the following ones.
Overall, I conclude that higher flow rates do not only lead to a more inefficient use of the
fuel (Figure 7.5a) but also to increased frictional losses (equation 7.7). In our demonstrated
devices, at low flow rates the power output more than compensated for the energy losses
from the viscous drag (Figure 7.5b). However, by comparing the performance of the device
at various flow rates, I concluded that the increase in the biotic power output at higher flow
110 High power density biological photovoltaic devices (BPVs)
rates is eventually counterbalanced by the elevated power consumption needed to overcome
the frictional losses. The optimal flow rate maximising the overall power output was found
to be around 20 µL h−1 and was as such used in all the following experiments.
7.3.4 Multiparameter optimisation of the BPV power output
Unlike devices, where photosynthetic cells transfer their electrons directly to the anode, I
used a design strategy where the charging and the power generation processes are spatially
decoupled. Combined with the use of mobile electron carriers that are free to move and
collect electrons from all the cells, this strategy has the potential to lead to elevated current
outputs when increasing the concentration of cells under otherwise identical conditions, for
as long as there is sufficient free electron carrier available in the system. I set out to test this
hypothesis by characterising the performance of the device at two different concentrations
of cells. I found that the peak power output increased with the cell concentration reaching
(22.2 ± 1.5) nW (average of n = 3 repeats) at chlorophyll concentration of 40 µM (Figure 7.6a).
I observed that the device yielded even larger power outputs at higher cell concentrations
and in particular, recorded the peak power output to be 65 nW at cchl = 80 µM. However,
adhesion of cells to the microfluidic channels was observed at the latter concentration which
could start to limit the performance of the device. As such, I restricted all the data presented
in this work to cchl = 40 µM where no difficulties with the operation were noted over a
several hour operation period. Different strategies can be implemented for circumventing
the problem of cell adhesion, such as treatment of the device surfaces. The increasing power
output with the cell concentration suggests that flow-based operation can provide a simple
approach to increase the power output of the devices, resulting in an advantage over systems
where the generated power is limited to the monolayer of the cells on the electrode.
Exoelectrogenic activity in wild-type photosynthetic organisms is not optimal for production
of photocurrent, since some of the electrons generated are subsequently consumed by a series
of electron sinks [250]. This is likely to reduce the power production. To overcome this
limitation, I generated a Synechocystis mutant deficient in the main photosynthetic and
respiratory electron sinks, the terminal oxidases (cytochrome c oxidase, quinol oxidase and
the alternative respiratory terminal oxidase), and the flavodiiron complexes, Flv1/3 and
Flv2/4 (Appendix A)[268, 269]. I predicted that the absence of these electron sinks would
lead to elevated exoelectrogenic activity and hence also to increased BPV power outputs.
Indeed, the characterisation of the BPV devices with mutant cells as the exoelectrogenic
catalyst yielded around twice as high power output than when the wild-type cells at the same
chlorophyll concentration were used (cchl = 40 µM), reaching a peak biotic power output of
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(a) (b)
Fig. 7.6 Enhanced performance of the µ-BPV. (a) An increase in the cell concentration
yields higher current and power outputs. (b) Using a mutant cells deficient in the
main photosynthetic and respiratory electron sinks, the anodic power density of
the BPVs doubled compared to using wild-type cells at the same cell concentration
(cchl = 40 µM).
(44.6 ± 1.6) nW (Figure 7.6a,b).
Continuous operation
We have shown that while flowing through the device, the cells and their exoelectrogenic
performance remains unaffected (Figure 7.4b). However, during every cycle some fraction of
the electron carrier molecules diffuses from the anodic area to the cathodic one, eventually
leading to a decrease in its overall concentration in the anolyte. To show that this diffusion
process does not affect the possibility to operate the devices continuously, I studied the device
performance by also including the electron carrier molecules [Fe(CN)6]3− in the catholyte
such that there would be no net movement of the [Fe(CN)6]3− ions from one side to another.
Crucially, this addition did not affect the device performance (Figure 7.7a). With the reduced
electron carrier molecule [Fe(CN)6]4− eventually oxidising back to [Fe(CN)6]3− (Figure 7.7b),
the system never runs short of the oxidised electron carrier [Fe(CN)6]3−, setting the basis for
continuous operation.
I further note that whereas the [Fe(CN)6]4− produced by the electrons released by the
photosynthetic cells oxidises slowly back to [Fe(CN)6]3−, the rate of this oxidation reaction
- measured to be around 5 nM s−1 (Figure 7.7b,c) - is significantly lower than that of the
[Fe(CN)6]−4 generation by the electrons released by the cells (280 nM s−1 - value determined
in Section 7.3.5). Although the elimination of oxygen could potentially prevent any back-
oxidation, the challenges associated with its removal are unlikely to outweigh the potential

















































































Fig. 7.7 Factors facilitating recirculating operation of the device. (a) The performance
of the device was similar when ferricyanide ions ([Fe(CN)6]3−) were included (orange
data points) and not included (black data points) in the cathodic fluid (both data
obtained with wild type cells at cchl = 8 µM). (b) Ferrocyanide ([Fe(CN)6]4−) oxidation
to ferricyanide ([Fe(CN)6]3−) in air over time. (c) The rate of this oxidation reaction
can be seen to be significantly slower than the rate of ferricyanide ([Fe(CN)6]3−)
reduction to ferrocyanide ([Fe(CN)6]4−) by the exoelectrogenic electrons released by
the wild type photosynthetic cells.
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gain, especially as oxygen removal could also affect the viability of the cells.
7.3.5 System scalability
I note that as opposed to previously described BPVs and conventional PVs, where the charging
and power generation process occur in a single compartment, for the spatially decoupled
design and operation described in this work, there is an additional area involved in the
charging process which can in general be different from the area used for the power generation
step. To allow for an effective comparison of our fabricated flow-BPVs with existing systems,
I set out to compare the areas involved in the illumination and the power harvesting processes.
For this purpose, I illuminated V = 3 mL of wild type cell suspension under a fixed area
of Aillumination = 1 cm2 and under typical light conditions of 2000 µE m−2 s−1 [270]. I
recorded spectroscopically that under these conditions, ferrocyanide was produced at a
rate of rtotal = 280 ± 60 nM s−1 (Figure 7.7c). The current flowing in our µ-BPV at its
peak power output (50 nA; Figure 7.4a) corresponds to ferrocyanide reduction rate of
rsingle-channel = 1.3 pmol s−1. I can therefore estimate the total number of channels required
for converting all the charged-up electron carrier into current, N, as
N = rtotalrsingle-channel
= 0.28 µM s
−1 · 3 mL
1.3 pmol s−1 = 1620 (7.10)
With the area of a single electrode being Aanode = 0.08 mm2, the total area required for
harvesting the power is Apower-delivery = 1.3 cm2, indicating that in the current work the area
required for illumination was of a similar size to the area required for power generation.
As there is no requirement for the power generation area to be exposed to sunlight, the illumi-
nation unit can be for instance be positioned above the power generation unit as illustrated
in Figure 7.8. I further note that in our experiments the geometry of the illumination unit
was not optimised; generation of larger quantities of the reduced electron carrier molecules is
possible (e.g. by using a deeper vessel), and the illumination area is thus not the limiting area
in the scalability consideration. As such, comparison of power densities normalised by the
power delivery area is an effective measure for understanding the scalability of the system.
The current system used a platinum wire as cathode, given its previously proven catalytic
activity for the re-generation of water. I tested whether a platinum plated wire could be
used instead of a platinum wire and found that whilst reducing the total cost of the system
the maximum power output of the system was indeed unaffected. Platinum plated steel
wires are available at a price of $0.02 per hundred metres ($35/kg). Using a conservative
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Fig. 7.8 By measuring the rate of ferrocyanide generation by the exoelectrogenic
electrons released by Synechocystis cells, the area required for this process was found
to be of the same size as the area required for converting these charged carriers to
current. As there is no requirement to expose the power generation unit to light, I
propose placing it underneath the charging unit.
estimate of a few centimetres of wire per chip, the cost of the amount of wire needed for a
thousand microfluidic chips is below a cent which is significantly smaller than the cost of a
microfluidic chip itself. Hence the use of platinum plated wires provides a promising approach
for reducing the cost of the system. Additionally, non-platinum based materials have been
shown to function effectively as the cathodic catalysts in microbial fuel cells [271, 272] and in
BPVs [273], providing an alternative strategy for reducing the cost of the system.
7.4 Discussion
In order to compare devices of different dimensions, current and power outputs are com-
monly normalised to the active surface area of the anode where the phototrophic cells are
located [250, 264]. As described in Section 7.3.5, for the two-chambered devices used in this
study, the areas involved in the power generation and the charging processes are of similar
sizes. As there is no requirement for the power generation area to be exposed to the sunlight,
I can use the former as the larger one of the two areas as a measure for estimating the
power density of the system and comparing the power outputs of the devices to previously
described systems. Using this approach, the peak power density for the described BPVs can be
estimated to be around (0.27 ± 0.03) W m−2 with the wild-type and (0.53 ± 0.05) W m−2




























Fig. 7.9 Comparison of the devices demonstrated in this work to previous BPV and
other power generation systems. The obtained power outputs are the highest BPV
power densities recorded to date - white markers correspond to previously described
devices [251] and the red and green marker to the device described in this work with wild-
type ((0.27 ± 0.03) W m−2) and mutant cells (0.53 ± 0.05) W m−2, respectively.
These values are similar to the power outputs of large scale biofuels and a factor of 10
to 20 lower than for large scale PVs [275–277].
our knowledge these values exceed that of previously demonstrated BPVs by two and a half
fold and by fivefold, respectively (Figure 7.9; [251]).
The several-fold improvement over previously described devices achieved in this work com-
bined with the advantages of BPVs, such as potentially cheap manufacturing and use of
self-replicating catalysts, indicate that when scaled up via parallelisation, flow-BPVs could
be a promising strategy for producing competitive analogues to synthetic photovoltaics
(Figure 7.9). Moreover, even without parallelisation, the power outputs an individual device
is sufficient for operating ultra-low power nanoelectronics, such as nanowire biosensors and
their small size could allow them to be used to build self-sustaining ystems via on-chip
integration [263, 274]. The decoupling “division-of-unit-processes” strategy described here
could potentially also be applied to non-biological photovoltaics or to hybrid devices where
conventional synthetic photovoltaic materials are employed in the charging process and an
independently optimised electrocatalytic process in the electrochemical conversion unit.
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7.5 Conclusion
In conclusion, I described and demonstrated a flow-based BPV system where the charging and
the power generation units are spatially decoupled from another. In contrast to previously
described devices, such decoupling provides temporal flexibility in power generation and the
opportunity to independently optimise the geometry and the conditions needed for the light
harvesting and the power generation processes. In particular, the use of microscale channels
in the power generation unit enabled me to separate the anolyte and catholyte streams and
dispense with the membranes, simplifying fabrication. Using this device, I achieved a two and
a half fold improvement over the highest power outputs recorded in any BPV using wild-type
cells and a fivefold improvement using a novel strain deficient in several electron sinks. I
envisage microscale devices to be a promising approach to optimise BPVs, thus opening a
path towards fulfilling their potential as a cheap and environmentally friendly complement to
non-biological photovoltaics.
Chapter 8
Conclusions and future directions
In this thesis, I demonstrated a range of micron scale devices and used them for analysing
the behaviour of biological systems, mostly proteins, both in vitro and in vivo. Specifically, I
made use of the diffusion controlled behaviour of molecules in confined environments to build
devices that allowed quantitative analysis of proteins, protein interactions and complexes,
and protein self-assembly directly in solution and at previously unprecedented timescales
and resolutions.
The self-assembly of proteins is a process that has been associated with the onset of a number
of disorders and it has also been employed actively for controlling the nanoscale structure
and properties of new materials. By exploiting the possibility to spatially decouple processes
while keeping them fluidically integrated, I built a microscale device for monitoring the
progression of aggregation in real time. In contrast to previously described high throughput
approaches, in these devices the aggregation process was tracked without the presence of
probe molecules in the reaction environment, which eliminated any potential interactions
between the probe molecules and the aggregation process. This principle of spatially decou-
pling chemical reactions from measurements could also be applied to other biochemical and
biophysical characterisation, where it is desirable to avoid interactions between the process
and measurement probes.
These devices enabled effective tracking of the total amount of aggregated protein species,
which can provide useful information on the aggregation process and kinetics. To gain further
insight into this process, it is highly desirable to have access to platforms that provide
size-resolved information about the compositions of self-assembling mixtures of proteins.
However, there is currently a lack of experimental tools that permit effective characterisation
self-assembling protein mixtures or, in fact, heterogeneous mixtures of biomolecules more
generally. Indeed, existing platforms do not operate in liquid phase, which prevents their use
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for analysing self-assembled protein complexes, as such larger species can obstruct the pores
of the matrices that conventional separation platforms employ for keeping analyte bands
confined.
To overcome these limitations and provide a strategy for separating biomolecules directly
in liquid, I used micron scale separation devices where mixing can be prevented and or-
derly separation achieved without the involvement of matrices. Specifically, I addressed two
limitations at the core of engineering such platforms. First, I devised and implemented a
strategy for integrating strong electric fields with micron scale channels. I achieved this
objective by the use of liquid electrodes that effectively transported away all electrolysis
products from the microfluidic chip before they came into contact with the micron scale
channels and perturbed the flow profiles in these channels. Secondly, I investigated the
main factors that contribute to the limited resolution limit of micron scale platforms and
demonstrated a strategy to increase several times the resolution of micron scale separation
platforms. This result was achieved by spatially controlling sample injection and thereby en-
abling simultaneous suppression of the factors otherwise responsible for the limited resolution.
Moreover, I combined this separation platform with a direct on chip protein sizing. This
combined platform allowed me to increase substantially the resolution limit of the downstream
analytical technique and to measure the sizes of proteins in mixtures that to the best of my
knowledge cannot be characterised with any existing sizing approach. Additionally, due to
the quantitative nature of the separation process, the strategy enabled me to obtain mul-
tidimensional data on mixtures of proteins directly in solution on a second to minute timescale.
In addition to in vitro biomolecular systems, I also used micron scale flow engineering ap-
proaches for analysing protein behaviour inside cells. Specifically, I demonstrated a platform
for detecting intracellular proteins inside individual cells across a large number of cells. The
presented work was concerned with detecting only a single target but the barcoding strategy
that I described can be extended straightforwardly to analysing a virtually unlimited number
of targets in parallel, overcoming the central limitation of existing single cell protein analysis
tools. The specific purification strategies that I used, enabled me to access intracellular
protein targets, which have not been previously detected in single cells in a highly multiplexed
and a high throughput manner.
Finally, I used the ability to tightly control fluid movement and molecular motion in micron
scale channels to build a conceptually new type of biological solar cell. This system relied on
photosynthetic cells for generating excited electrons that could be converted into electrical
current. By spatially decoupling the two key processes involved in the operation of a solar
cell - the generation of excited charge carriers and their conversion into current - I was able
to optimise the performance of these two processes independently. In so doing, I achieved
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an enhancement which many times exceeded the power densities of previously described
biophotovoltaic systems. The strategy to decouple charge generation and power delivery
spatially additionally equipped the system with a temporal flexibility in power generation,
which has been viewed as one of the key drawbacks of previous photovoltaic devices.
I envisage a broad range of applications for the microfluidic strategies described in this thesis.
In particular, I am continuing to use the rapid in-solution separation approach for probing
highly dynamic and heterogeneous biological systems. I have been delighted to see the interest
that this work has generated both academically among my collaborators and commercially.
The multidimensional protein characterisation strategy forms the basis of an explorative
protein analysis and identification platform that I am hoping to have demonstrated soon.
I am very interested in using the latter approach for further analysing protein behaviour
and interactions inside a complex cellular environment, providing an orthogonal strategy
for single cell proteomic analysis to the one that I described in this thesis that could be
performed in a sequencing-free and in a probe-free manner.

Appendix A
Generation of electron transport
chain mutants
A.1 Plasmid construction
The primers used in this study are listed in Table A.1. PCR was performed by standard
procedures using Phusion high fidelity DNA polymerase (NEB). The genome sequence of
Synechocystis sp. PCC6803 was consulted via Cyanobase
(http://genome.kazusa.or.jp/cyanobase) for primer design [278]. Gene deletion of flv2 was
performed by amplifying a 912bp fragment upstream of flv2 using primers Flv2leftfor
and Flv2leftrev and a 972bp fragment downstream of flv2 using primers Flv2rightfor and
Flv2rightrev, followed by insertion of the respective fragments into the SacI/EcoRI and
XbaI/BamHI sites of pUC19 to generate pFlv2-1. Gene deletion of flv3 was performed by
amplifying a 918bp fragment upstream of flv3 using primers Flv3leftfor and Flv3leftrev and a
964bp fragment downstream of flv3 using primers Flv3rightfor and Flv3rightrev, followed by
insertion of the respective fragments into the SacI/EcoRI and XbaI/BamHI sites of pUC19
to generate Flv3-1. The BamHI digested npt1/sacRB cassette from pUM24Cm was inserted
into the BamHI site between the upstream and downstream fragments in pFlv2-1 and pFlv3-1
to generate pFlv2-2 and pFlv3-2 respectively [279].
A.2 Generation of recombinant strains of
Synechocystis sp. PCC 6803
Unmarked mutants of Synechocystis lacking Flv2 and Flv3 were constructed by disruption
of flv2 and flv3, respectively, in the terminal oxidase mutant deficient strain via a two step
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Table A.1 Sequence of primers used in this study.∗













homologous recombination protocol [123]. To generate marked mutants approximately 1 µg
of plasmids pFlv2-2 and pFlv3-2 were mixed with Synechocystis cells for 6 hours in liquid
medium, followed by incubation on BG-11 agar plates for approximately 24 hours. An
additional 3 mL of agar containing kanamycin was added to the surface of the plate followed
by further incubation for approximately 1-2 weeks. Transformants were subcultured to allow
segregation of mutant alleles. Segregation was confirmed by PCR using primers Flv2f/Flv2r,
or Flv3f/Flv3r, which flank the deleted region. Generation of unmarked mutants was carried
out according to Lea-Smith et al. [269]. To remove the npt1/sacRB cassette, mutant lines
were transformed with 1 µg of the markerless pFlv2-1 and pFlv3-1 constructs. Following
incubation in BG-11 liquid medium for 4 days and on agar plates containing sucrose (5% w/v)
for a further 1-2 weeks, transformants were patched on kanamycin and sucrose plates. Sucrose
resistant, kanamycin sensitive strains containing the unmarked deletion were confirmed by
PCR using primers flanking the deleted region (Fig. A.1).
A.2 Generation of recombinant strains of




Fig. A.1 Schematic representations of locus location in the Synechocystis sp. PCC6803
genome (top) and the wild type (middle) and unmarked knockouts (bottom) profiles
expected in (a) ∆Flv2 and (b) ∆Flv3 strains following amplification with primers
flanking the deleted sequence. Regions deleted in the mutant strains are shaded in
black. (c) Amplification of genomic DNA in wild type cells (lane 2) and ∆Flv2 (lane 3)
using Flv2f and Flv2r primers; in wild type (lane 4) and Flv3 (lane 5) using Flv3f and
Flv3r primers. DNA marker ladder is in Lane 1.
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